Data / Research funding / Dementia
Dementia: 8,438 NIH awards ($15.5B) to 792 organizations
8,438 NIH awards ($15.5B) in the NIH spending category Dementia, to 792 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 8,438 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Health and Retirement Study: Yrs 35-40 | NIH | National Institute on Aging | 2021 to 2025 | $142,220,153 | September 25, 1990 | December 31, 2029 | WEIR, DAVID R. | reporter.nih.gov |
| Alzheimer's Clinical Trials Consortium (ACTC) | NIH | National Institute on Aging | 2021 to 2025 | $119,771,576 | December 2, 2017 | August 31, 2028 | AISEN, PAUL S. | reporter.nih.gov |
| Alzheimer's Disease Neuroimaging Initiative (ADNI4) | NIH | National Institute on Aging | 2022 to 2025 | $95,332,786 | September 30, 2004 | July 31, 2028 | WEINER, MICHAEL W | reporter.nih.gov |
| Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS) | NIH | National Institute on Aging | 2021 to 2025 | $82,684,947 | September 30, 2020 | August 31, 2026 | HANDEN, BENJAMIN L | reporter.nih.gov |
| DIAN-TU Primary Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $79,373,454 | September 15, 2018 | May 31, 2026 | MCDADE, ERIC MARTIN | reporter.nih.gov |
| NIA AD/ADRD Health Care Systems Research Collaboratory | NIH | National Institute on Aging | 2021 to 2025 | $69,169,841 | September 1, 2019 | August 31, 2030 | MOR, VINCENT | reporter.nih.gov |
| Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project | NIH | National Institute on Aging | 2022 to 2025 | $66,521,567 | September 1, 2022 | August 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | NIH | National Institute on Aging | 2021 to 2025 | $65,403,220 | July 15, 2002 | May 31, 2027 | FOROUD, TATIANA M. | reporter.nih.gov |
| The National Health and Aging Trends Study and National Study of Caregiving | NIH | National Institute on Aging | 2021 to 2025 | $65,386,641 | September 30, 2008 | March 31, 2029 | SCHRACK, JENNIFER ANN | reporter.nih.gov |
| The Alzheimer's Disease Tau Platform Clinical Trial | NIH | National Institute on Aging | 2023 to 2024 | $60,700,604 | September 21, 2023 | August 31, 2028 | BOXER, ADAM L. | reporter.nih.gov |
| ADRC Consortium for Clarity in ADRD Research Through Imaging | NIH | National Institute on Aging | 2023 to 2024 | $60,357,563 | September 15, 2023 | August 31, 2028 | JOHNSON, STERLING C | reporter.nih.gov |
| The Long Life Family Study | NIH | National Institute on Aging | 2021 to 2025 | $60,108,132 | August 15, 2019 | June 30, 2030 | PROVINCE, MICHAEL A. | reporter.nih.gov |
| ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) | NIH | National Institute on Aging | 2021 to 2025 | $56,766,232 | September 15, 2019 | August 31, 2030 | BOEVE, BRADLEY F | reporter.nih.gov |
| DIAN-TU: Tau Next Generation Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $49,839,335 | September 15, 2020 | May 31, 2027 | BATEMAN, RANDALL J | reporter.nih.gov |
| A multimodal brain cell atlas and community resource of Alzheimer's disease and comorbid dementias. | NIH | National Institute on Aging | 2021 to 2025 | $48,445,852 | March 1, 2020 | August 31, 2030 | LEIN, ED | reporter.nih.gov |
| National Alzheimer's Coordinating Center | NIH | National Institute on Aging | 2021 to 2025 | $45,845,722 | June 15, 2021 | May 31, 2027 | STEPHENS, KARI A | reporter.nih.gov |
| IU/JAX/PITT MODEL-AD Center | NIH | National Institute on Aging | 2021 to 2025 | $45,129,948 | September 30, 2016 | August 31, 2027 | LAMB, BRUCE T | reporter.nih.gov |
| Longitudinal multicenter head-to-head harmonization of tau PET tracers | NIH | National Institute on Aging | 2021 to 2025 | $41,111,092 | September 1, 2021 | May 31, 2027 | PASCOAL, THARICK | reporter.nih.gov |
| UC Irvine MODEL-AD | NIH | National Institute on Aging | 2021 to 2025 | $40,119,354 | September 15, 2017 | August 31, 2027 | LAFERLA, FRANK M | reporter.nih.gov |
| Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months | NIH | National Institute on Aging | 2021 to 2025 | $39,702,286 | June 1, 2020 | May 31, 2027 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Wisconsin longitudinal study: Initial lifetime's impact on Alzheimer's disease and related disorders (WLS-ILIAD) | NIH | National Institute on Aging | 2021 to 2025 | $39,317,019 | September 15, 2018 | February 29, 2028 | ASTHANA, SANJAY | reporter.nih.gov |
| Study of Muscle, Mobility and Aging: SOMMA2 | NIH | National Institute on Aging | 2021 to 2025 | $38,028,895 | June 15, 2018 | June 30, 2029 | CUMMINGS, STEVEN RON | reporter.nih.gov |
| Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium | NIH | National Institute on Aging | 2021 to 2025 | $37,497,984 | September 30, 2021 | August 31, 2026 | HOHMAN, TIMOTHY J | reporter.nih.gov |
| Cognitive training to reduce incidence of cognitive impairment in older adults | NIH | National Institute on Aging | 2021 to 2024 | $37,326,564 | February 1, 2021 | January 31, 2027 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| Health and Aging Brain among Latino Elders (HABLE-AT(N)) Study | NIH | National Institute on Aging | 2021 to 2025 | $36,277,689 | August 1, 2020 | April 30, 2027 | O'BRYANT, SID E | reporter.nih.gov |
| Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study | NIH | National Institute on Aging | 2021 to 2024 | $36,190,244 | August 15, 2020 | May 31, 2025 | ABUSHAKRA, SUSAN | reporter.nih.gov |
| Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP) | NIH | National Institute on Aging | 2022 to 2025 | $35,910,792 | July 1, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD) | NIH | National Institute on Aging | 2021 to 2025 | $35,388,433 | March 1, 2021 | May 31, 2026 | KIND, AMY J. | reporter.nih.gov |
| The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $35,158,235 | February 15, 2021 | January 31, 2027 | LAH, JAMES J | reporter.nih.gov |
| Combination anti-amyloid therapy for preclinical Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2024 | $34,903,050 | September 30, 2018 | May 31, 2025 | AISEN, PAUL S. | reporter.nih.gov |
| A Next Generation Data Infrastructure to Understand Disparities across the Life Course | NIH | National Institute on Aging | 2023 to 2025 | $34,372,705 | August 15, 2023 | July 31, 2028 | KAPTEYN, ARIE | reporter.nih.gov |
| Education and Cognitive Functioning in Later Life: The Nation’s High School Class of 1972 | NIH | National Institute on Aging | 2024 to 2025 | $32,776,590 | September 30, 2022 | July 31, 2027 | MULLER, CHANDRA L | reporter.nih.gov |
| Early Onset AD Consortium - the LEAD Study (LEADS) | NIH | National Institute on Aging | 2021 to 2023 | $31,594,379 | September 30, 2018 | May 31, 2025 | APOSTOLOVA, LIANA G | reporter.nih.gov |
| IUSM TREAT-AD Center | NIH | National Institute on Aging | 2021 to 2025 | $31,208,587 | September 30, 2019 | November 30, 2029 | PALKOWITZ, ALAN D. | reporter.nih.gov |
| Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $30,295,384 | July 15, 2022 | June 30, 2028 | GIBSON, GARY E | reporter.nih.gov |
| The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) | NIH | National Institute on Aging | 2024 to 2025 | $30,281,212 | August 15, 2024 | July 31, 2029 | BOXER, ADAM L. | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies | NIH | National Institute on Aging | 2021 to 2023 | $29,498,064 | May 15, 2021 | April 30, 2025 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial | NIH | National Institute on Aging | 2021 to 2025 | $28,784,116 | August 15, 2019 | April 30, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $28,395,368 | September 1, 2022 | August 31, 2027 | SILVA, AFONSO C | reporter.nih.gov |
| Bridge Funding for Dominantly Inherited Alzheimer Network | NIH | National Institute on Aging | 2021 to 2025 | $27,724,157 | September 15, 2008 | June 30, 2026 | BATEMAN, RANDALL J | reporter.nih.gov |
| The INCLUDE Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $27,560,616 | September 26, 2020 | August 31, 2030 | RESNICK, ADAM CAIN | reporter.nih.gov |
| API A4 Alzheimer's Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $26,251,396 | September 1, 2018 | November 30, 2025 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| ASPirin in Reducing Events in the Elderly - eXTension | NIH | National Institute on Aging | 2021 to 2023 | $24,851,437 | July 15, 2019 | April 30, 2026 | MURRAY, ANNE M | reporter.nih.gov |
| US POINTER Neuroimaging Ancillary Study | NIH | National Institute on Aging | 2021 to 2025 | $24,762,483 | August 1, 2019 | March 31, 2027 | LANDAU, SUSAN M | reporter.nih.gov |
| Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia | NIH | National Institute on Aging | 2021 to 2024 | $24,586,693 | September 15, 2020 | May 31, 2026 | FARRER, LINDSAY A. | reporter.nih.gov |
| Center without Walls for Imaging Proteinopathies with PET | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $24,457,384 | September 24, 2019 | July 31, 2029 | MACH, ROBERT H | reporter.nih.gov |
| Asian Cohort for Alzheimer's Disease (ACAD) | NIH | National Institute on Aging | 2023 to 2025 | $24,263,451 | July 1, 2023 | June 30, 2028 | WANG, LI-SAN | reporter.nih.gov |
| Metformin in Alzheimer's dementia Prevention (MAP) | NIH | National Institute on Aging | 2021 to 2025 | $24,224,790 | August 15, 2019 | April 30, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Integrating Information about Aging Surveys: Novel Integration of Contextual Data to Study Late-Life Cognition and Alzheimer’s Disease and Related Dementia and Dementia Care | NIH | National Institute on Aging | 2021 to 2025 | $23,672,206 | May 1, 2007 | March 31, 2027 | LEE, JINKOOK | reporter.nih.gov |
| Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study | NIH | National Institute on Aging | 2021 to 2024 | $23,438,396 | May 15, 2019 | December 31, 2025 | SPERLING, REISA A. | reporter.nih.gov |
| Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $23,431,388 | August 15, 2021 | July 31, 2027 | MUCKE, LENNART | reporter.nih.gov |
| Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | NIH | National Institute on Aging | 2023 to 2025 | $23,106,653 | August 15, 2023 | July 31, 2028 | DE ERAUSQUIN, GABRIEL ALEJANDRO | reporter.nih.gov |
| Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO) | NIH | National Institute on Aging | 2021 to 2025 | $23,099,141 | September 30, 2021 | August 31, 2027 | PERLS, THOMAS T | reporter.nih.gov |
| THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE | NIH | National Institute on Aging | 2021 to 2025 | $21,982,300 | April 1, 2012 | April 30, 2027 | WANG, LI-SAN | reporter.nih.gov |
| Wisconsin Registry for Alzheimer's Prevention | NIH | National Institute on Aging | 2023 to 2025 | $21,491,270 | June 1, 2023 | February 29, 2028 | JOHNSON, STERLING C | reporter.nih.gov |
| BRAIN CONNECTS: A Center for High-throughput Integrative Mouse Connectomics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $21,489,807 | September 8, 2023 | August 31, 2028 | LICHTMAN, JEFF W | reporter.nih.gov |
| APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $21,355,638 | September 30, 2020 | March 31, 2027 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| Unraveling the earliest phases of vascular cognitive impairment and dementia using CADASIL--a monogenic form of small vessel cerebrovascular disease | NIH | National Institute on Aging | 2021 to 2025 | $21,188,740 | September 30, 2021 | August 31, 2027 | PAULSEN, JANE S | reporter.nih.gov |
| Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging | NIH | National Institute on Aging | 2021 to 2025 | $21,174,898 | September 30, 2021 | May 31, 2027 | DEMIRIS, GEORGE | reporter.nih.gov |
| A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB) | NIH | National Institute on Aging | 2023 to 2025 | $21,072,036 | February 1, 2023 | January 31, 2026 | ALAM, JOHN | reporter.nih.gov |
| Delaware Clinical and Translational Research ACCEL Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,011,968 | September 25, 2013 | June 30, 2028 | HICKS, GREGORY E | reporter.nih.gov |
| The Origins of Alzheimer Disease in African Americans | NIH | National Institute on Aging | 2022 to 2025 | $20,889,453 | September 15, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Alzheimer's Gut Microbiome Project | NIH | National Institute on Aging | 2021 to 2023 | $20,743,566 | September 15, 2019 | August 31, 2025 | KADDURAH-DAOUK, RIMA F | reporter.nih.gov |
| Frontotemporal Dementia: Genes, Images, and Emotions | NIH | National Institute on Aging | 2021 to 2025 | $20,694,825 | September 1, 2002 | April 30, 2028 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in Cohort of Oldest-Old | NIH | National Institute on Aging | 2022 to 2025 | $20,680,832 | September 15, 2017 | June 30, 2027 | WHITMER, RACHEL A | reporter.nih.gov |
| Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative | NIH | National Institute on Aging | 2022 to 2024 | $20,575,729 | September 1, 2022 | August 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial Program | NIH | National Institute on Aging | 2024 to 2025 | $20,406,409 | September 1, 2024 | August 31, 2029 | ALEXANDER, ROBERT C | reporter.nih.gov |
| Einstein Aging Study | NIH | National Institute on Aging | 2021 to 2024 | $20,102,748 | September 29, 1982 | March 31, 2028 | DERBY, CAROL A. | reporter.nih.gov |
| Massachusetts Alzheimer's Disease Research Center (MADRC) | NIH | National Institute on Aging | 2021 to 2025 | $19,915,545 | May 15, 2019 | March 31, 2029 | GOMEZ-ISLA, TERESA | reporter.nih.gov |
| National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS) | NIH | National Institute on Aging | 2021 to 2025 | $19,881,397 | August 1, 2017 | April 30, 2027 | MAYEUX, RICHARD P | reporter.nih.gov |
| UCSD Shiley-Marcos Alzheimer's Disease Research Center P30 | NIH | National Institute on Aging | 2021 to 2025 | $18,959,959 | May 1, 2019 | March 31, 2029 | BREWER, JAMES B | reporter.nih.gov |
| Health, Aging and Dementia in South Africa: A Longitudinal Study (HAALSI) | NIH | National Institute on Aging | 2021 to 2025 | $18,706,904 | September 15, 2013 | May 31, 2028 | BERKMAN, LISA F | reporter.nih.gov |
| Mayo Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $18,486,241 | July 1, 2019 | April 30, 2029 | BOEVE, BRADLEY F | reporter.nih.gov |
| Lifecourse health, cerebral pathology and differences in dementia risk (KHANDLE Study) | NIH | National Institute on Aging | 2021 to 2025 | $18,022,067 | June 1, 2016 | February 28, 2027 | WHITMER, RACHEL A | reporter.nih.gov |
| Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $17,997,906 | May 15, 2022 | January 31, 2028 | GONZALEZ, HECTOR M | reporter.nih.gov |
| Mount Sinai Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,735,870 | May 1, 2020 | March 31, 2030 | SANO, MARY | reporter.nih.gov |
| Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study | NIH | National Institute on Aging | 2021 to 2024 | $17,711,217 | September 1, 2019 | August 31, 2029 | LEE, CECILIA SUNGMIN | reporter.nih.gov |
| Additional Sequencing for the Alzheimer's Disease Sequencing Project (ADSP) | NIH | National Institute on Aging | 2021 to 2024 | $17,661,924 | July 1, 2020 | June 30, 2026 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,255,961 | June 15, 2020 | April 30, 2030 | SMALL, SCOTT A | reporter.nih.gov |
| Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal) | NIH | National Institute on Aging | 2021 to 2025 | $17,112,209 | August 15, 2018 | May 31, 2029 | HUGHES, TIMOTHY M. | reporter.nih.gov |
| Offspring Study of Mechanisms for Racial Disparities in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $17,095,138 | September 1, 2016 | May 31, 2027 | MANLY, JENNIFER JAIE | reporter.nih.gov |
| NORTHWESTERN Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,093,229 | August 15, 2021 | June 30, 2026 | VASSAR, ROBERT J | reporter.nih.gov |
| Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias | NIH | National Institute on Aging | 2022 to 2025 | $17,073,728 | September 1, 2022 | June 30, 2027 | NORRIS, CHRISTOPHER MARK | reporter.nih.gov |
| Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) | NIH | National Institute on Aging | 2023 to 2025 | $17,039,516 | August 15, 2023 | April 30, 2028 | HARRIS, KATHLEEN MULLAN | reporter.nih.gov |
| Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort | NIH | National Institute on Aging | 2021 to 2025 | $16,952,609 | July 1, 2009 | May 31, 2027 | ALBERT, MARILYN S. | reporter.nih.gov |
| Goizueta Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $16,684,611 | July 15, 2020 | April 30, 2030 | LEVEY, ALLAN I | reporter.nih.gov |
| Diabetes and brain amyloid in middle aged Hispanics | NIH | National Institute on Aging | 2021 to 2025 | $16,383,484 | September 1, 2015 | May 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Cognition & Hippocampal/Cortical Systems in Aging | NIH | National Institute on Aging | 2021 to 2025 | $16,383,227 | September 1, 1997 | March 31, 2027 | KNIERIM, JAMES J | reporter.nih.gov |
| National Social Life, Health, and Aging Project: Round 5 | NIH | National Institute on Aging | 2021 to 2025 | $16,330,170 | September 15, 2014 | April 30, 2029 | WAITE, LINDA J | reporter.nih.gov |
| University of Kansas Alzheimer's Disease Research Center (KU ADRC) | NIH | National Institute on Aging | 2021 to 2025 | $16,309,323 | August 15, 2021 | June 30, 2026 | SWERDLOW, RUSSELL H. | reporter.nih.gov |
| Understanding Cohort Effects on Stroke, VCID, and Cognition After Major Epidemiologic Transitions | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $16,244,011 | September 24, 2001 | August 31, 2026 | JUDD, SUZANNE E | reporter.nih.gov |
| National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VI Cognition and Early Risk Factors for Dementia Project | NIH | National Institute on Aging | 2021 to 2025 | $16,156,406 | January 15, 2021 | December 31, 2026 | HUMMER, ROBERT A | reporter.nih.gov |
| The Alzheimer's Disease Research Center at the University of California, Irvine | NIH | National Institute on Aging | 2021 to 2025 | $16,032,156 | June 15, 2020 | March 31, 2030 | LAFERLA, FRANK M | reporter.nih.gov |
| Alzheimer's Disease Genetics Consortium | NIH | National Institute on Aging | 2021 to 2024 | $15,948,152 | April 1, 2009 | March 31, 2026 | SCHELLENBERG, GERARD DAVID | reporter.nih.gov |
| Arizona Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $15,728,435 | September 5, 2021 | June 30, 2027 | LANGBAUM, JESSICA BROOKE | reporter.nih.gov |
| Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond | NIH | National Institute on Aging | 2021 to 2022 | $15,706,591 | May 15, 2019 | February 29, 2024 | WARREN, JOHN ROBERT | reporter.nih.gov |
| ARIC Neurocognitive Study (ARIC-NCS) Renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $15,682,941 | July 7, 2010 | March 31, 2024 | CORESH, JOSEF | reporter.nih.gov |
| Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias | NIH | National Institute on Aging | 2021 to 2025 | $15,514,157 | September 30, 2021 | May 31, 2027 | ELLERBY, LISA M | reporter.nih.gov |
| Center for Pacific Innovations, Knowledge, and Opportunities (PIKO) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $15,507,862 | September 1, 2021 | July 31, 2027 | KAHOLOKULA, JOSEPH KEAWE'AIMOKU | reporter.nih.gov |
| The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 4) | NIH | National Institute on Aging | 2021 to 2024 | $15,274,483 | September 1, 2015 | March 31, 2026 | PANIZZON, MATTHEW S | reporter.nih.gov |
| NIH NATIONAL BRAIN AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,799,056 | May 1, 2025 | October 31, 2025 | reporter.nih.gov | |
| Johns Hopkins University Trial Innovation Center | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $14,762,337 | July 5, 2023 | April 30, 2028 | HANLEY, DANIEL F | reporter.nih.gov |
| English Longitudinal Study of Ageing - Renewal 2024 | NIH | National Institute on Aging | 2021 to 2025 | $14,720,227 | September 30, 2000 | May 31, 2029 | STEPTOE, ANDREW | reporter.nih.gov |
| Alzheimer's Disease Research Centers | NIH | National Institute on Aging | 2021 to 2025 | $14,719,450 | September 1, 2020 | March 31, 2030 | CHUI, HELENA CHANG | reporter.nih.gov |
| Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies | NIH | National Institute on Aging | 2022 to 2025 | $14,689,794 | September 15, 2019 | December 31, 2026 | PERLS, THOMAS T | reporter.nih.gov |
| Causes and Consequences of Healthcare Inefficiency in Alzheimer’s Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $14,684,279 | August 1, 2001 | July 31, 2028 | BARNATO, AMBER E | reporter.nih.gov |
| Alzheimer's Disease Research Center - Administrative Supplement 2025 | NIH | National Institute on Aging | 2021 to 2025 | $14,671,380 | May 1, 2020 | April 30, 2026 | WISNIEWSKI, THOMAS M | reporter.nih.gov |
| Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $14,626,193 | May 1, 2017 | April 30, 2024 | AISEN, PAUL S. | reporter.nih.gov |
| Advancing cross-disease comparisons through FAIR data practices to uncover shared molecular mechanisms between Alzheimer's disease and autoimmune disorders | NIH | National Institute on Aging | 2021 to 2025 | $14,514,376 | September 1, 2025 | April 30, 2027 | HEATH, LAURA MICHELLE | reporter.nih.gov |
| Integrative Pathways to Cognitive, Affective, and Brain Health | NIH | National Institute on Aging | 2022 to 2025 | $14,488,542 | September 30, 2022 | August 31, 2028 | RYFF, CAROL D. | reporter.nih.gov |
| Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks | NIH | National Institute on Aging | 2021 to 2024 | $14,414,001 | September 15, 2020 | August 31, 2025 | THOMPSON, PAUL M | reporter.nih.gov |
| Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study | NIH | National Institute on Aging | 2022 to 2025 | $14,339,100 | August 15, 2022 | July 31, 2028 | DEAL, JENNIFER ANNE | reporter.nih.gov |
| Mild Cognitive Impairment: A Prospective Community Study | NIH | National Institute on Aging | 2021 to 2025 | $14,337,476 | September 1, 2005 | April 30, 2026 | GANGULI, MARY | reporter.nih.gov |
| National Social Life, Health, and Aging Project: Rounds 4.2 and 4.4 | NIH | National Institute on Aging | 2021 to 2025 | $14,285,263 | September 1, 2013 | February 28, 2027 | WAITE, LINDA J | reporter.nih.gov |
| Study of Healthy Aging in African Americans | NIH | National Institute on Aging | 2023 to 2025 | $14,240,222 | January 1, 2017 | May 31, 2028 | WHITMER, RACHEL A | reporter.nih.gov |
| The Mobile Toolbox for Monitoring Cognitive and Behavioral Function (MTB2) | NIH | National Institute on Aging | 2021 to 2024 | $14,206,304 | September 15, 2018 | May 31, 2029 | GERSHON, RICHARD | reporter.nih.gov |
| Education and Cognitive Functioning in Later Life: The Nation’s High School Class of 1972 | NIH | National Institute on Aging | 2022 to 2023 | $14,187,625 | September 30, 2022 | July 31, 2027 | MULLER, CHANDRA L | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,117,524 | April 1, 2019 | September 30, 2026 | GUSTAFSON, DEBORAH R. | reporter.nih.gov |
| Vanderbilt Memory & Aging Project | NIH | National Institute on Aging | 2021 to 2025 | $14,019,775 | March 15, 2011 | March 31, 2027 | JEFFERSON, ANGELA L. | reporter.nih.gov |
| Multicultural Community Dementia Screening | NIH | National Institute on Aging | 2021 to 2025 | $13,797,203 | May 1, 2021 | January 31, 2027 | GALVIN, JAMES E | reporter.nih.gov |
| Wyoming Sensory Biology COBRE | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,747,906 | September 1, 2017 | July 31, 2027 | SUN, QIAN-QUAN | reporter.nih.gov |
| Admin. Supp.: Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,703,967 | May 15, 2023 | April 30, 2028 | DOUDNA, JENNIFER A | reporter.nih.gov |
| A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimerʼs Disease | NIH | National Institute on Aging | 2021 | $13,634,548 | September 15, 2018 | May 31, 2024 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Lysosome Regulation and Signaling in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $13,495,371 | June 1, 2021 | February 28, 2027 | ZHENG, HUI | reporter.nih.gov |
| 1Florida Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $13,348,245 | June 15, 2020 | April 30, 2027 | SMITH, GLENN E. | reporter.nih.gov |
| Epidemiological and Genetic Investigations of Blood-Based Biomarkers for Alzheimer's Disease in the Multiethnic, Washington Heights, Inwood, Columbia Aging Project (WHICAP) | NIH | National Institute on Aging | 2021 to 2025 | $13,310,071 | June 1, 2021 | March 31, 2027 | MAYEUX, RICHARD P | reporter.nih.gov |
| ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028 | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $13,305,831 | July 7, 2010 | March 31, 2029 | CORESH, JOSEF | reporter.nih.gov |
| MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS | NIH | National Institute on Aging | 2021 to 2025 | $13,186,351 | September 1, 2020 | May 31, 2027 | AGGARWAL, NEELUM T. | reporter.nih.gov |
| Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Surveys in India (LASI) | NIH | National Institute on Aging | 2021 to 2025 | $13,167,007 | September 15, 2015 | April 30, 2026 | LEE, JINKOOK | reporter.nih.gov |
| Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood | NIH | National Institute on Aging | 2023 to 2025 | $12,972,426 | September 1, 2023 | May 31, 2028 | KARIKARI, THOMAS K | reporter.nih.gov |
| The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2023 | $12,937,549 | August 15, 2016 | April 30, 2024 | SPERLING, REISA A. | reporter.nih.gov |
| Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | NIH | National Institute on Aging | 2022 to 2025 | $12,690,286 | April 15, 2017 | April 30, 2027 | KAPLAN, HILLARD S | reporter.nih.gov |
| Medicare at a Crossroads | NIH | National Institute on Aging | 2021 to 2025 | $12,593,170 | August 15, 2009 | April 30, 2030 | LANDON, BRUCE E. | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects with P. gingivalis-Positive Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $12,591,952 | August 15, 2025 | July 31, 2029 | DETKE, MICHAEL J. | reporter.nih.gov |
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects | NIH | National Institute on Aging | 2021 to 2022 | $12,573,346 | May 1, 2019 | February 28, 2023 | DIDSBURY, JOHN | reporter.nih.gov |
| Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $12,536,106 | February 15, 2022 | November 30, 2026 | MURRAY, MELISSA ERIN | reporter.nih.gov |
| Center for Addiction and Disease Risk Exacerbation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,487,946 | August 1, 2019 | July 31, 2029 | MONTI, PETER M. | reporter.nih.gov |
| Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan | NIH | National Institute on Aging | 2021 to 2024 | $12,295,034 | February 15, 2020 | November 30, 2025 | OTTMAN, RUTH | reporter.nih.gov |
| Exploring Cognitive Aging Using Reference Ability Neural Networks | NIH | National Institute on Aging | 2021 to 2025 | $12,167,937 | September 1, 2011 | June 30, 2027 | STERN, YAAKOV | reporter.nih.gov |
| Center for Research and Education on Aging and Technology Enhancement - CREATE | NIH | National Institute on Aging | 2022 to 2025 | $12,069,399 | June 15, 2022 | May 31, 2027 | CZAJA, SARA J | reporter.nih.gov |
| Alzheimers Disease Patient Registry (Administrative Supplement) | NIH | National Institute on Aging | 2021 to 2023 | $11,991,901 | September 30, 1986 | June 30, 2026 | PETERSEN, RONALD C | reporter.nih.gov |
| A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,962,900 | September 30, 2021 | July 31, 2027 | LUCIANO, MARK GREGORY | reporter.nih.gov |
| DIAN-TU: Next Generation Prevention Trial | NIH | National Institute on Aging | 2022 to 2023 | $11,960,034 | September 1, 2017 | May 31, 2024 | BATEMAN, RANDALL J | reporter.nih.gov |
| Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems. | NIH | National Institute on Aging | 2021 to 2025 | $11,898,685 | September 15, 2007 | May 31, 2029 | TRIVEDI, AMAL N. | reporter.nih.gov |
| I3C DECADE: Developmental Epidemiology of Childhood Cardiovascular Exposures and Alzheimer’s Dementia | NIH | National Institute on Aging | 2022 to 2025 | $11,889,015 | July 1, 2022 | April 30, 2028 | MACLEHOSE, RICHARD F | reporter.nih.gov |
| REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | NIH | National Institute on Aging | 2024 to 2025 | $11,773,020 | January 1, 2024 | December 31, 2028 | ELY, E WESLEY | reporter.nih.gov |
| Cross Sectional and Longitudinal Racial Disparity in Molecular Biomarkers of Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $11,652,217 | June 1, 2020 | March 31, 2026 | XIONG, CHENGJIE | reporter.nih.gov |
| Kynurenine accumulation drives loss of muscle and bone function with aging | NIH | National Institute on Aging | 2021 to 2025 | $11,563,609 | May 1, 2011 | May 31, 2027 | ISALES, CARLOS M. | reporter.nih.gov |
| Estrogens, Cardiometabolic Health, and Female Cognitive Aging | NIH | National Institute on Aging | 2022 to 2025 | $11,521,268 | March 1, 2022 | February 28, 2027 | DANIEL, JILL M | reporter.nih.gov |
| Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $11,497,463 | May 15, 2022 | April 30, 2027 | DONG, HONG-WEI | reporter.nih.gov |
| Sleep in Neurocognitive Aging and Alzheimers Research (SANAR) | NIH | National Institute on Aging | 2021 to 2025 | $11,494,462 | February 1, 2021 | January 31, 2027 | RAMOS, ALBERTO RAFAEL | reporter.nih.gov |
| Impact of Neuroinflammation on AD Occurrence: A Bi-Generational Population Study | NIH | National Institute on Aging | 2021 to 2025 | $11,418,675 | September 1, 2021 | May 31, 2027 | RAJAN, KUMAR B. | reporter.nih.gov |
| Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry | NIH | National Institute on Aging | 2021 to 2025 | $11,411,820 | February 1, 2021 | January 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $11,402,108 | September 30, 2004 | May 31, 2027 | BARNES, LISA L | reporter.nih.gov |
| Complement Mediated Remodeling in Pulmonary Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $11,355,302 | August 1, 2020 | June 30, 2026 | STENMARK, KURT R. | reporter.nih.gov |
| Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline | NIH | National Institute on Aging | 2021 to 2024 | $11,354,079 | August 1, 2020 | July 31, 2025 | GUPTA, ADITI | reporter.nih.gov |
| Circuit-specific cell types in aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $11,340,010 | June 1, 2022 | May 31, 2028 | LEE, KUO-FEN | reporter.nih.gov |
| Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil | NIH | National Institute on Aging | 2023 to 2025 | $11,334,713 | August 15, 2023 | July 31, 2028 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,282,768 | September 15, 2018 | July 31, 2029 | BENATAR, MICHAEL | reporter.nih.gov |
| The Longitudinal Course of Imaging Biomarkers in People At Risk for Alzheimer’s Disease | NIH | National Institute on Aging | 2022 to 2025 | $11,223,576 | August 15, 2004 | March 31, 2027 | JOHNSON, STERLING C | reporter.nih.gov |
| KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology | NIH | National Institute on Aging | 2021 to 2025 | $11,202,386 | August 15, 2021 | July 31, 2027 | SAYKIN, ANDREW J | reporter.nih.gov |
| Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $10,898,840 | May 15, 2022 | April 30, 2027 | XU, XIANGMIN | reporter.nih.gov |
| A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $10,874,349 | April 1, 2019 | June 30, 2025 | FELDMAN, HOWARD | reporter.nih.gov |
| Longitudinal Imaging Biomarkers of Prodromal DLB | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,821,041 | September 25, 2017 | August 31, 2027 | KANTARCI, KEJAL | reporter.nih.gov |
| Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis | NIH | National Institute on Aging | 2024 to 2025 | $10,584,728 | September 30, 2008 | May 31, 2029 | BATEMAN, RANDALL J | reporter.nih.gov |
| Arterial Stiffness, Cognition, and Equol (ACE) | NIH | National Institute on Aging | 2022 to 2025 | $10,581,052 | February 15, 2022 | January 31, 2027 | SEKIKAWA, AKIRA | reporter.nih.gov |
| VCID Biomarkers Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $10,493,954 | September 30, 2016 | June 30, 2027 | GREENBERG, STEVEN M | reporter.nih.gov |
| The INCLUDE Project Down Syndrome Biorepository (DS-Biorepository) | NIH | National Institute on Aging | 2024 to 2025 | $10,436,444 | September 30, 2024 | August 31, 2029 | ESPINOSA, JOAQUIN M. | reporter.nih.gov |
| Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA. | NIH | National Institute on Aging | 2022 to 2025 | $10,320,460 | February 15, 2022 | January 31, 2027 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study | NIH | National Institute on Aging | 2021 to 2024 | $10,318,677 | April 15, 2019 | January 31, 2026 | ELY, E WESLEY | reporter.nih.gov |
| Alzheimer's Disease and Related Dementias (ADRD) prevalence in American Samoa | NIH | National Institute on Aging | 2022 to 2025 | $10,293,481 | September 30, 2022 | August 31, 2027 | TOFAEONO, VAATAUSILI T | reporter.nih.gov |
| NIH Health Care Systems Research Collaboratory-Coordinating Center (U24) | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $10,249,994 | September 22, 2022 | May 31, 2028 | HERNANDEZ, ADRIAN | reporter.nih.gov |
| Vermont Center for Cardiovascular and Brain Health | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $10,185,844 | August 6, 2020 | May 31, 2026 | CUSHMAN, MARY | reporter.nih.gov |
| ACTIVE MIND: An adaptive clinical trial of cognitive training to improve function and delay dementia | NIH | National Institute on Aging | 2022 to 2023 | $10,112,651 | September 1, 2022 | June 24, 2024 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and Susceptibility | NIH | National Institute on Aging | 2021 to 2024 | $9,901,034 | May 1, 2021 | February 28, 2026 | REDLINE, SUSAN S. | reporter.nih.gov |
| LifeâÂÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial | NIH | National Institute on Aging | 2021 to 2022 | $9,892,823 | September 15, 2020 | April 30, 2026 | MINTZER, JACOBO | reporter.nih.gov |
| Gateway Exposome Coordinating Center (GECC) For AD/ADRD Research | NIH | National Institute on Aging | 2024 to 2025 | $9,887,007 | August 1, 2024 | July 31, 2029 | LEE, JINKOOK | reporter.nih.gov |
| Vanderbilt Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,726,538 | December 1, 1996 | March 31, 2027 | POWERS, ALVIN C | reporter.nih.gov |
| DEploying High ValuE LOngitudinal Population-Based dAta in Dementia Research (DEVELOP AD Research) | NIH | National Institute on Aging | 2021 to 2024 | $9,684,597 | September 30, 2020 | May 31, 2026 | MORRISON, R. SEAN | reporter.nih.gov |
| Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging) | NIH | National Institute on Aging | 2023 to 2025 | $9,673,461 | September 30, 2021 | August 31, 2027 | ROGALSKI, EMILY J | reporter.nih.gov |
| National Swine Resource and Research Center (NSRRC) Years 21-25 | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,635,041 | September 1, 2003 | July 31, 2028 | LEE, KIHO | reporter.nih.gov |
| TASK ORDER 1 - OCR PROJECT MANAGEMENT, DSMB AND CROMS-RELATED SUPPORT | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,613,167 | March 25, 2024 | March 24, 2026 | APPELMANS, ELINE | reporter.nih.gov |
| Collaborative Approach for Asian Americans, Native Hawaiians, and Pacific Islanders Research and Education (CARE) 2.0 | NIH | National Institute on Aging | 2023 to 2025 | $9,607,843 | August 1, 2023 | June 30, 2028 | PARK, VAN MY TA | reporter.nih.gov |
| Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study) | NIH | National Institute on Aging | 2022 to 2025 | $9,488,371 | August 1, 2022 | July 31, 2027 | ZHANG, RONG | reporter.nih.gov |
| BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial | NIH | National Institute on Aging | 2021 to 2025 | $9,481,336 | February 15, 2021 | November 30, 2026 | HANLEY, DANIEL F | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2025 | $9,466,491 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,439,774 | March 10, 2016 | June 30, 2027 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,418,230 | September 1, 2021 | August 31, 2026 | GOATE, ALISON M | reporter.nih.gov |
| TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABI | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,377,344 | May 1, 2025 | October 31, 2025 | reporter.nih.gov | |
| Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order | NIH | National Institute on Aging | 2021 to 2024 | $9,373,073 | June 1, 2020 | March 31, 2026 | MAYEUX, RICHARD P | reporter.nih.gov |
| The San Antonio Heart and Mind Study | NIH | National Institute on Aging | 2023 to 2025 | $9,286,743 | July 1, 2023 | March 31, 2029 | SATIZABAL, CLAUDIA L | reporter.nih.gov |
| African Americans Fighting Alzheimer’s in Midlife (AA-FAIM) | NIH | National Institute on Aging | 2021 to 2025 | $9,250,399 | August 1, 2016 | November 30, 2027 | GLEASON, CAREY E | reporter.nih.gov |
| Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimer’s disease pathogenesis in the BEACoN Cohort | NIH | National Institute on Aging | 2021 to 2025 | $9,240,061 | August 1, 2017 | December 31, 2027 | YASSA, MICHAEL A | reporter.nih.gov |
| The Care Ecosystem Response to COVID-19: Accelerating Research on Dementia Care that Meets the Needs of Caregivers and Persons with Dementia during COVID-19 | NIH | National Institute on Aging | 2022 to 2024 | $9,143,854 | June 15, 2022 | May 31, 2026 | POSSIN, KATHERINE LAUREL | reporter.nih.gov |
| Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,106,321 | September 29, 2021 | August 31, 2026 | DONNELLY, CHRISTOPHER JAMES | reporter.nih.gov |
| Center of Excellence in Environmental Toxicology | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $9,096,433 | April 1, 2006 | May 31, 2030 | PENNING, TREVOR M | reporter.nih.gov |
| Resilience and brain health of older adults | NIH | National Institute on Aging | 2021 to 2025 | $9,066,206 | August 15, 2021 | May 31, 2027 | LENZE, ERIC J | reporter.nih.gov |
| NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE - Alzheimer's disease | NIH | National Institute of Mental Health | 2023 to 2025 | $9,005,480 | August 23, 2023 | August 22, 2026 | HADIJAH, VACTOR | reporter.nih.gov |
| Epidemiologic Study of Neural Reserve and Neurobiology of Aging | NIH | National Institute on Aging | 2021 to 2023 | $8,995,869 | September 30, 2001 | May 31, 2026 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Center for Stress and Neural Regulation of Reproductive Aging Health Outcomes | NIH | National Institute on Aging | 2021 to 2025 | $8,986,759 | June 1, 2020 | August 31, 2030 | JOFFE, HADINE | reporter.nih.gov |
| Consequences of Incarceration on Health, Age-Related Conditions, and Risk Factors for ADRD | NIH | National Institute on Aging | 2024 to 2025 | $8,887,003 | August 15, 2024 | April 30, 2029 | TEPLIN, LINDA A | reporter.nih.gov |
| Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN Supplement | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $8,842,412 | July 1, 2016 | June 30, 2023 | HANLEY, DANIEL F | reporter.nih.gov |
| Risk Factors, Pathology, and Clinical Expressions of AD | NIH | National Institute on Aging | 2021 to 2024 | $8,703,055 | July 15, 1998 | April 30, 2026 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions | NIH | National Institute on Aging | 2021 to 2025 | $8,654,669 | July 1, 2021 | June 30, 2027 | TEMPLE, SALLY | reporter.nih.gov |
| Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond | NIH | National Institute on Aging | 2023 to 2024 | $8,554,832 | May 15, 2019 | February 28, 2026 | WARREN, JOHN ROBERT | reporter.nih.gov |
| P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer’s Disease continuum in South Asians in India | NIH | National Institute on Aging | 2024 to 2025 | $8,548,820 | September 15, 2024 | August 31, 2029 | NARAYAN, KABAYAM M VENKAT | reporter.nih.gov |
| Alzheimer variants: Propagation of shared functional changes across cellular networks | NIH | National Institute on Aging | 2021 to 2025 | $8,542,236 | July 15, 2021 | June 30, 2027 | DE JAGER, PHILIP L | reporter.nih.gov |
| Preserving Cognitive Resilience: A Biracial Parent-Offspring Study | NIH | National Institute on Aging | 2022 to 2024 | $8,461,054 | March 1, 2019 | May 31, 2026 | RAJAN, KUMAR B. | reporter.nih.gov |
| Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models | NIH | National Institute on Aging | 2021 to 2025 | $8,376,812 | July 1, 2021 | June 30, 2026 | SHULMAN, JOSHUA M | reporter.nih.gov |
| Genetic Architecture of Alzheimer’s disease Proteinopathies | NIH | National Institute on Aging | 2021 to 2024 | $8,376,544 | April 15, 2021 | February 28, 2026 | KAMBOH, M. ILYAS | reporter.nih.gov |
| Genetic Studies of Alzheimer's Disease in Jewish and Arab Populations | NIH | National Institute on Aging | 2023 to 2025 | $8,372,205 | September 1, 2023 | August 31, 2028 | FARRER, LINDSAY A. | reporter.nih.gov |
| Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $8,348,817 | September 15, 2022 | May 31, 2027 | ALBER, JESSICA | reporter.nih.gov |
| ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA | NIH | National Institute on Aging | 2022 to 2025 | $8,306,361 | June 15, 2022 | March 31, 2027 | MESULAM, MAREK-MARSEL M | reporter.nih.gov |
| Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies | NIH | National Institute on Aging | 2021 to 2025 | $8,305,058 | July 1, 2021 | June 30, 2026 | MONTINE, THOMAS J | reporter.nih.gov |
| Exceptional Longevity Data Management and Coordinating Center | NIH | National Institute on Aging | 2022 to 2025 | $8,296,806 | September 1, 2022 | July 31, 2027 | VARMA, SUSHEEL | reporter.nih.gov |
| A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $8,293,749 | September 30, 2021 | August 31, 2026 | ZAIDI, MONE | reporter.nih.gov |
| Gulf Coast Center for Precision Environmental Health | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $8,275,327 | May 15, 2019 | May 31, 2029 | WALKER, CHERYL L. | reporter.nih.gov |
| Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials | NIH | National Institute on Aging | 2021 to 2023 | $8,244,109 | February 1, 2019 | January 31, 2025 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| The Physical Biology of Neurodegeneration in Sporadic Amyotrophic Lateral Sclerosis/Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,227,499 | September 1, 2021 | August 31, 2027 | PHATNANI, HEMALI | reporter.nih.gov |
| GLASS-AD: Global Latinos Sequencing Study for Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2025 | $8,212,071 | September 30, 2023 | August 31, 2028 | TOSTO, GIUSEPPE | reporter.nih.gov |
| Race / Ethncicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemmorrhage | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $8,210,604 | February 1, 2016 | July 31, 2027 | ROSAND, JONATHAN | reporter.nih.gov |
| Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,189,971 | September 15, 2024 | August 31, 2026 | GITLER, AARON D. | reporter.nih.gov |
| Emergency General Surgery Delirium Recovery Model: A Collaborative Care Intervention | NIH | National Institute on Aging | 2022 to 2025 | $8,173,947 | July 1, 2022 | June 30, 2027 | ZARZAUR, BEN L | reporter.nih.gov |
| Disordered Proteostasis as a Driver of Disease in the Aging Lung | NIH | National Institute on Aging | 2021 to 2024 | $8,161,610 | July 1, 2015 | March 31, 2025 | BUDINGER, GR SCOTT | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial | NIH | National Institute on Aging | 2021 to 2022 | $8,118,116 | April 1, 2017 | September 30, 2024 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| Racial/Ethnic Disparities in ADRD Risk: The Impact of Social Relations | NIH | National Institute on Aging | 2021 to 2024 | $8,105,276 | June 1, 2020 | March 31, 2026 | ANTONUCCI, TONI CLAUDETTE | reporter.nih.gov |
| Characterizing the Genetic Risk for Alzheimer Disease in African and Admixed African-American Ancestries | NIH | National Institute on Aging | 2024 to 2025 | $8,032,655 | September 30, 2024 | August 31, 2029 | GRISWOLD, ANTHONY JOHN | reporter.nih.gov |
| Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project | NIH | National Institute on Aging | 2022 to 2025 | $7,983,648 | June 1, 2022 | May 31, 2027 | JACKLIN, KRISTEN | reporter.nih.gov |
| CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan | NIH | National Institute of Mental Health | 2022 to 2025 | $7,973,681 | February 1, 2022 | November 30, 2026 | LETENDRE, SCOTT L | reporter.nih.gov |
| Indiana Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,959,091 | July 6, 2015 | May 31, 2030 | EVANS-MOLINA, CARMELLA | reporter.nih.gov |
| THE NIH PRECISION BRAIN HEALTH NETWORK: Open and Inclusive Measurement of Neuropsychological Change for AD/ADRD Primary Prevention Trials | NIH | National Institute on Aging | 2025 | $7,948,867 | August 1, 2025 | July 31, 2030 | SLIWINSKI, MARTIN J | reporter.nih.gov |
| Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia | NIH | National Institute on Aging | 2023 to 2025 | $7,878,167 | September 15, 2017 | August 31, 2028 | ROGALSKI, EMILY J | reporter.nih.gov |
| Higher Order Chromatin and Genetic Risk for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,828,464 | September 1, 2015 | May 31, 2027 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Claude D. Pepper Older Americans Independence Center at Yale | NIH | National Institute on Aging | 2021 to 2025 | $7,769,010 | September 30, 2002 | June 30, 2028 | GILL, THOMAS MICHAEL | reporter.nih.gov |
| ERICH-GENE | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,768,356 | August 1, 2010 | June 30, 2025 | DEMEL, STACIE | reporter.nih.gov |
| The POINTER Neurovascular Ancillary Study | NIH | National Institute on Aging | 2021 to 2024 | $7,761,498 | April 15, 2020 | December 31, 2025 | BRINKLEY, TINA E | reporter.nih.gov |
| Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $7,757,977 | July 1, 2021 | June 30, 2027 | KAYED, RAKEZ | reporter.nih.gov |
| Mapping the vulnerable locus coeruleus pathways in aging and AD | NIH | National Institute on Aging | 2022 to 2025 | $7,731,727 | August 15, 2022 | July 31, 2027 | CHUNG, KWANGHUN | reporter.nih.gov |
| SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging | NIH | National Institute on Aging | 2021 to 2025 | $7,600,838 | May 1, 2020 | April 30, 2027 | JAGUST, WILLIAM J. | reporter.nih.gov |
| Vietnamese Insights into Cognitive Aging Program (VIP) | NIH | National Institute on Aging | 2021 to 2025 | $7,598,841 | February 15, 2021 | May 31, 2026 | MEYER, OANH L | reporter.nih.gov |
| Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD | NIH | National Institute on Aging | 2021 to 2025 | $7,592,411 | August 15, 2021 | May 31, 2027 | UDEH-MOMOH, CHINEDU THERESA | reporter.nih.gov |
| Genotyping the Understanding America Study to generate novel opportunities for research on cognitive functioning and dementia | NIH | National Institute on Aging | 2023 to 2025 | $7,564,979 | September 15, 2023 | May 31, 2028 | GALAMA, TITUS JOHANNES | reporter.nih.gov |
| THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITE(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,530,975 | May 1, 2025 | October 31, 2025 | SCOTT, WILLIAM | reporter.nih.gov |
| A major contributor of serious multisystem disease in the elderly: varicella zoster virus-induced inflammation | NIH | National Institute on Aging | 2021 to 2023 | $7,526,233 | March 1, 2009 | December 31, 2025 | NAGEL, MARIA ACENA | reporter.nih.gov |
| Plasma Proteomic Signatures for Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 | $7,523,227 | September 15, 2022 | August 31, 2025 | SHADYAB, ALADDIN | reporter.nih.gov |
| REpeated ASseSsmEnt of SurvivorS in ICH (REASSESS ICH) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $7,516,765 | January 1, 2022 | December 31, 2027 | ZIAI, WENDY C | reporter.nih.gov |
| Indigenous Cultural Understandings of Alzheimer's Disease and Related Dementias - Research and Engagement (I-CARE) | NIH | National Institute on Aging | 2021 to 2025 | $7,489,463 | March 1, 2021 | February 28, 2027 | JACKLIN, KRISTEN | reporter.nih.gov |
| Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $7,486,964 | February 15, 2020 | January 31, 2026 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients | NIH | National Institute on Aging | 2021 to 2022 | $7,416,643 | September 15, 2020 | May 31, 2023 | MOEBIUS, HANS JOERG | reporter.nih.gov |
| Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience | NIH | National Institute on Aging | 2021 to 2024 | $7,413,273 | September 15, 2020 | May 31, 2025 | SESHADRI, SUDHA | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2023 to 2024 | $7,403,993 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimers Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,389,501 | January 15, 2021 | December 31, 2026 | RAO, STEPHEN MARK | reporter.nih.gov |
| Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders | NIH | National Institute on Aging | 2021 to 2025 | $7,375,647 | July 1, 2021 | December 31, 2026 | REITZ, ALLEN BERNARD | reporter.nih.gov |
| Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities Framework | NIH | National Institute on Aging | 2022 to 2025 | $7,350,257 | February 15, 2022 | November 30, 2027 | COHEN, ANN D. | reporter.nih.gov |
| Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II) | NIH | National Institute on Aging | 2024 to 2025 | $7,286,036 | June 15, 2024 | November 30, 2029 | JOHNSON-AKEJU, OLUWASEUN | reporter.nih.gov |
| Leveraging the 24-hour movement paradigm to preserve cognitive function and prevent Alzheimer's disease: The Multi-Ethnic Study of Atherosclerosis (MESA) 24H-ACT Study | NIH | National Institute on Aging | 2021 to 2024 | $7,263,372 | May 1, 2021 | April 30, 2026 | DIAZ, KEITH M | reporter.nih.gov |
| The VETSA Longitudinal MRI Twin Study of Aging (VETSA MRI 4) | NIH | National Institute on Aging | 2022 to 2025 | $7,252,240 | June 1, 2022 | March 31, 2027 | ELMAN, JEREMY A | reporter.nih.gov |
| Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging | NIH | National Institute on Aging | 2022 to 2025 | $7,239,829 | August 15, 2022 | June 30, 2027 | CRUCHAGA, CARLOS | reporter.nih.gov |
| Aging eyes and aging brains in studying alzheimer''s disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study | NIH | National Institute on Aging | 2025 | $7,155,353 | September 1, 2019 | April 30, 2029 | LEE, CECILIA SUNGMIN | reporter.nih.gov |
| Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,153,018 | July 1, 2021 | June 30, 2027 | ZHI, DEGUI | reporter.nih.gov |
| Escitalopram for Agitation in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2022 | $7,145,681 | September 30, 2016 | May 31, 2024 | LYKETSOS, CONSTANTINE G | reporter.nih.gov |
| Developing a NAMPT activator for Alzheimer’s disease | NIH | National Institute on Aging | 2023 to 2025 | $7,056,557 | September 15, 2023 | August 31, 2028 | CHEN, BEIBEI | reporter.nih.gov |
| Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2023 | $7,036,460 | September 15, 2019 | May 31, 2025 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts. | NIH | National Institute on Aging | 2021 to 2022 | $6,989,910 | September 1, 2020 | August 31, 2025 | ERTEKIN-TANER, NILUFER | reporter.nih.gov |
| University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC) | NIH | National Institute on Aging | 2021 to 2025 | $6,970,364 | September 15, 2006 | June 30, 2027 | RYAN, ALICE S. | reporter.nih.gov |
| UCSF Older Americans Independence Center | NIH | National Institute on Aging | 2021 to 2025 | $6,946,581 | July 15, 2013 | June 30, 2028 | COVINSKY, KENNETH E. | reporter.nih.gov |
| Multidimensional mapping of vulnerable cell types in humanized Alzheimer's disease mouse models | NIH | National Institute on Aging | 2023 to 2025 | $6,945,316 | July 1, 2023 | March 31, 2028 | COBOS, INMA | reporter.nih.gov |
| Differential Effects of Exercise Modality on Cognition and Brain in Older Adults | NIH | National Institute on Aging | 2021 to 2025 | $6,923,080 | April 1, 2021 | March 31, 2027 | VIDONI, ERIC DENNIS | reporter.nih.gov |
| Risk Factors for Future Cognitive Decline and Alzheimers Disease in Older African Americans | NIH | National Institute on Aging | 2021 to 2025 | $6,919,789 | May 15, 2018 | May 31, 2028 | GLUCK, MARK A | reporter.nih.gov |
| Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,908,458 | July 15, 2021 | June 30, 2027 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| Lifetime stressors and Alzheimer's Disease genetic variants and biomarkers in relation to cognitive decline among Black Women'sHealth Study participants. | NIH | National Institute on Aging | 2024 to 2025 | $6,906,113 | February 15, 2024 | January 31, 2029 | ROSENBERG, LYNN | reporter.nih.gov |
| Clinical trials to prevent Alzheimer's Disease in Down Syndrome | NIH | National Institute on Aging | 2022 to 2024 | $6,863,895 | September 15, 2019 | August 31, 2025 | RAFII, MICHAEL S | reporter.nih.gov |
| GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $6,827,181 | June 1, 2022 | May 31, 2027 | WATTERSON, DANIEL MARTIN | reporter.nih.gov |
| The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease | NIH | National Institute on Aging | 2023 to 2025 | $6,770,771 | May 15, 2023 | January 31, 2028 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Examining the Persistence of Neurocognitive Benefits of Exercise | NIH | National Institute on Aging | 2023 to 2025 | $6,759,799 | September 1, 2023 | May 31, 2028 | ERICKSON, KIRK I | reporter.nih.gov |
| Artificial Intelligence Strategies for Alzheimer's Disease Research | NIH | National Institute on Aging | 2022 to 2025 | $6,749,268 | September 30, 2021 | August 31, 2026 | MOORE, JASON H. | reporter.nih.gov |
| North Carolina Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,742,732 | April 7, 2020 | May 31, 2028 | NEUFER, P DARRELL | reporter.nih.gov |
| Adapting the ShedMEDS Deprescribing Intervention to Dementia Care in Assisted Living | NIH | National Institute on Aging | 2021 to 2023 | $6,628,141 | August 15, 2019 | July 31, 2024 | STEINMAN, MICHAEL A. | reporter.nih.gov |
| Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $6,621,893 | September 15, 2020 | May 31, 2026 | WANG, JIN | reporter.nih.gov |
| Cell Specific Perturbations of the Proteome in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,610,744 | September 30, 2021 | July 31, 2027 | YATES III, JOHN R | reporter.nih.gov |
| Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,609,782 | September 30, 2014 | August 31, 2030 | BENATAR, MICHAEL | reporter.nih.gov |
| A Pragmatic Trial of the UCSF Brain Health Assessment for the Detection of Cognitive Impairment in Primary Care | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $6,593,404 | September 15, 2022 | August 31, 2027 | POSSIN, KATHERINE LAUREL | reporter.nih.gov |
| Precision Editing of Granulin Mutations that Cause Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $6,580,415 | August 15, 2025 | July 31, 2029 | SONTHEIMER, ERIK J. | reporter.nih.gov |
| Life-course social adversity, pesticide exposure, and cognitive outcomes among an ongoing cohort of mid-life Latina women in an under served agricultural region | NIH | National Institute on Aging | 2021 to 2024 | $6,569,013 | September 15, 2020 | May 31, 2026 | TORRES, JACQUELINE MARIE | reporter.nih.gov |
| Dementia with Lewy Bodies Consortium | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $6,563,373 | September 30, 2016 | August 31, 2027 | LEVERENZ, JAMES BRUCE | reporter.nih.gov |
| Technology to Realize the Full Potential of UHF MRI | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,553,989 | February 1, 2019 | January 31, 2029 | METZGER, GREGORY JOHN | reporter.nih.gov |
| The RAW Brain - The Effect of Rumination, Anxiety and Worry on Aging and Dementia Risk | NIH | National Institute of Mental Health | 2021 to 2025 | $6,507,641 | September 20, 2016 | June 30, 2027 | ANDREESCU, CARMEN | reporter.nih.gov |
| The effects of Alzheimer's disease risk genes on metabolism and signaling across cell types | NIH | National Institute on Aging | 2022 to 2025 | $6,477,664 | September 19, 2022 | August 31, 2027 | FRAENKEL, ERNEST | reporter.nih.gov |
| Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk | NIH | National Institute on Aging | 2021 to 2025 | $6,475,434 | August 15, 2021 | May 31, 2027 | WEINKAUF, CRAIG C | reporter.nih.gov |
| The Ante-Amyloid Treatment of Alzheimer's disease (A3) Trial and Alzheimer Plasma EXtension (APEX) Study | NIH | National Institute on Aging | 2025 | $6,467,513 | September 1, 2025 | August 31, 2030 | SPERLING, REISA A. | reporter.nih.gov |
| The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study | NIH | National Institute on Aging | 2021 to 2024 | $6,442,962 | June 15, 2020 | March 31, 2025 | VERGHESE, JOE | reporter.nih.gov |
| Trends and Dynamics in Caregiving for Alzheimer’s Disease and Related Dementias: Extending the National Study of Caregiving | NIH | National Institute on Aging | 2021 to 2023 | $6,436,858 | June 15, 2019 | May 31, 2026 | FREEDMAN, VICKI A. | reporter.nih.gov |
| Moderation of Aging Trajectories of Cognition and Neuropathology by Diet Composition in Middle-aged Nonhuman Primates | NIH | National Institute on Aging | 2025 | $6,424,607 | September 15, 2025 | September 14, 2029 | BAXTER, MARK G | reporter.nih.gov |
| Contributions of stress reactivity to risk of Alzheimer's disease and related dementia's in a community-based cohort | NIH | National Institute on Aging | 2021 to 2025 | $6,416,931 | September 30, 2021 | May 31, 2027 | KERSHAW, KIARRI N | reporter.nih.gov |
| Validation of the Remote Cognitive Aging and Alzheimer’s Disease REsearch (R-CARE) Toolbox for Diverse Populations | NIH | National Institute on Aging | 2023 to 2025 | $6,381,700 | August 15, 2023 | May 31, 2028 | LIPTON, RICHARD B. | reporter.nih.gov |
| Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL | NIH | National Institute on Aging | 2022 to 2025 | $6,381,039 | September 1, 2022 | May 31, 2027 | HAINES, JONATHAN L | reporter.nih.gov |
| Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $6,353,055 | May 15, 2020 | April 30, 2026 | TSAI, LI-HUEI | reporter.nih.gov |
| Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimer’s disease and its related dementias | NIH | National Institute on Aging | 2021 to 2025 | $6,336,090 | September 15, 2021 | May 31, 2027 | HYACINTH, HYACINTH IDU | reporter.nih.gov |
| The spectrum of cognitive impairment including Alzheimer’s Disease and Related Dementias after liver transplantation | NIH | National Institute on Aging | 2021 to 2025 | $6,330,805 | June 15, 2018 | May 31, 2028 | LAI, JENNIFER C. | reporter.nih.gov |
| A Life Course Approach to Integrating Trauma and Cognitive Aging: A Cohort of 9/11 Responders | NIH | National Institute on Aging | 2021 to 2024 | $6,329,240 | May 15, 2015 | April 30, 2026 | CLOUSTON, SEAN | reporter.nih.gov |
| Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,313,088 | September 30, 2021 | August 31, 2026 | ZAIDI, MONE | reporter.nih.gov |
| Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $6,308,426 | August 15, 2024 | July 31, 2029 | ALOSCO, MICHAEL | reporter.nih.gov |
| PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial | NIH | National Institute on Aging | 2022 to 2025 | $6,295,083 | February 15, 2022 | January 31, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $6,265,868 | February 1, 2021 | November 30, 2026 | POTTER, HUNTINGTON | reporter.nih.gov |
| The NH Explanatory Trials Network: Supporting Transformation by Enhancing Partnerships (The NEXT STEPS). | NIH | National Institute on Aging | 2024 to 2025 | $6,261,370 | September 1, 2024 | May 31, 2029 | UNROE, KATHLEEN T | reporter.nih.gov |
| Validation of Biomarkers of Small Vessel Injury in VCID | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,258,167 | September 29, 2021 | July 31, 2026 | ROSENBERG, GARY ALLEN | reporter.nih.gov |
| Longitudinal Examination of Neighborhood Disadvantage, Cognitive Aging, and Alzheimer's Disease Risk in Disinvested, African American Neighborhoods | NIH | National Institute on Aging | 2022 to 2024 | $6,229,431 | February 15, 2022 | January 31, 2025 | DUBOWITZ, TAMARA | reporter.nih.gov |
| Washington University University of Texas Southwestern VCID Consortium Site | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,224,729 | September 29, 2021 | July 31, 2026 | LEE, JIN-MOO | reporter.nih.gov |
| Expanding insights into FTD disease mechanisms | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $6,199,699 | December 1, 2016 | November 30, 2024 | PETRUCELLI, LEONARD | reporter.nih.gov |
| IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia | NIH | National Institute on Aging | 2021 to 2023 | $6,168,197 | April 15, 2020 | March 31, 2024 | HAY, MEREDITH | reporter.nih.gov |
| Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,142,337 | September 30, 2019 | July 31, 2025 | MCKEE, ANN C. | reporter.nih.gov |
| Imaging Genetics of Brain Structure and Cognitive Aging in Murine Models of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,121,279 | February 1, 2021 | January 31, 2027 | WILLIAMS, ROBERT W. | reporter.nih.gov |
| The University of Kentucky MarkVCID Biomarker Validation Cohort: Development of a Toolbox to Advance VCID Interventional Studies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,120,000 | September 29, 2021 | July 31, 2026 | JICHA, GREGORY A | reporter.nih.gov |
| Elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes | NIH | National Institute on Aging | 2022 to 2025 | $6,109,739 | September 15, 2022 | August 31, 2027 | SHEN, YIN | reporter.nih.gov |
| Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials | NIH | National Institute on Aging | 2021 to 2023 | $6,105,662 | September 1, 2019 | March 21, 2025 | LANGBAUM, JESSICA BROOKE | reporter.nih.gov |
| MarkVCID Validation in the General Community | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,100,999 | September 23, 2021 | July 31, 2026 | PETERSEN, RONALD C | reporter.nih.gov |
| Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions | NIH | National Institute on Aging | 2023 to 2025 | $6,093,858 | June 1, 2023 | February 29, 2028 | XU, XIANGMIN | reporter.nih.gov |
| Long-Term Nicotine Treatment of Mild Cognitive Impairment | NIH | National Institute on Aging | 2022 | $6,088,879 | September 15, 2015 | January 31, 2026 | NEWHOUSE, PAUL A. | reporter.nih.gov |
| Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD) | NIH | National Institute on Aging | 2022 | $6,065,228 | September 15, 2022 | August 31, 2025 | BOXER, ADAM L. | reporter.nih.gov |
| CNS Mechanisms Linking Exercise Training with Energy Balance and Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $6,058,407 | September 20, 2019 | August 31, 2025 | ELMQUIST, JOEL K. | reporter.nih.gov |
| Diagnosis and Risk factors of hippocampal sclerosis of aging and limbic predominant age related TDP-43 encephalopathy; common Alzheimer’s mimics | NIH | National Institute on Aging | 2021 to 2025 | $6,052,469 | April 1, 2019 | May 31, 2029 | SAJJADI, SEYED AHMAD | reporter.nih.gov |
| Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients | NIH | National Institute on Aging | 2021 to 2024 | $6,046,063 | August 1, 2020 | July 31, 2025 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach | NIH | National Institute on Aging | 2021 to 2022 | $6,002,449 | September 15, 2018 | May 31, 2024 | INOUYE, SHARON K. | reporter.nih.gov |
| Decoding the impact of sex differences on Alzheimer's disease risk | NIH | National Institute on Aging | 2021 to 2025 | $5,985,073 | September 15, 2021 | June 30, 2027 | LICHTARGE, OLIVIER | reporter.nih.gov |
| Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $5,966,043 | June 1, 2022 | May 31, 2027 | ZHANG, SHIJUN | reporter.nih.gov |
| Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum | NIH | National Institute on Aging | 2021 to 2025 | $5,959,465 | September 15, 2021 | May 31, 2027 | CHIOSIS, GABRIELA | reporter.nih.gov |
| VCID CWOW: Identifying Novel Targets to Treat Cerebral Amyloid Angiopathy | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $5,949,022 | September 18, 2024 | August 31, 2027 | HOWELL, GARETH R | reporter.nih.gov |
| Integration of immune cell subtypes across diseases & tissue | NIH | National Institute on Aging | 2021 to 2022 | $5,948,190 | September 30, 2018 | August 31, 2023 | DE JAGER, PHILIP L | reporter.nih.gov |
| URBAn Native Elders (URBANE): Risk and Protective Factors for Alzheimer's and Related Dementias | NIH | National Institute on Aging | 2021 to 2024 | $5,941,036 | September 1, 2019 | May 31, 2026 | NELSON, LONNIE A. | reporter.nih.gov |
| Dissecting the role of sex-linked genes and APOE e4 risk in AD | NIH | National Institute on Aging | 2021 to 2025 | $5,928,484 | September 30, 2021 | July 31, 2027 | YOUNG, JESSICA ELAINE | reporter.nih.gov |
| Chaperome networks in Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2025 | $5,927,093 | February 15, 2021 | January 31, 2027 | CHIOSIS, GABRIELA | reporter.nih.gov |
| Penn PET Addiction Center of Excellence (PACE) | NIH | National Institute on Drug Abuse | 2021 to 2023 | $5,914,143 | August 15, 2019 | June 30, 2025 | MACH, ROBERT H | reporter.nih.gov |
| THE PURPOSE OF THIS TASK ORDER IS TO PROVIDE THE NATIONAL INSTITUTE ON AGING WITH INFORMATION RESOURCE CENTER SERVICES IN ACCORDANCE WITH THE ATTACHED STATEMENT OF WORK AND QUOTE DATED 8/1/2025. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $5,908,784 | September 16, 2025 | September 15, 2026 | reporter.nih.gov | |
| PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study | NIH | National Institute on Aging | 2023 to 2025 | $5,906,221 | September 1, 2023 | August 31, 2027 | HAY, MEREDITH | reporter.nih.gov |
| Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 to 2025 | $5,896,816 | August 15, 2022 | May 31, 2027 | KANTHASAMY, ANUMANTHA GOUNDER | reporter.nih.gov |
| Late-onset Unexplained Epilepsy as a Risk Factor for Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $5,883,988 | September 1, 2023 | February 28, 2029 | LAM, ALICE D | reporter.nih.gov |
| A Proteomic Comparison of Sporadic Early-Onset, Late-Onset, and Autosomal Dominant Alzheimer's Disease | NIH | National Institute on Aging | 2024 to 2025 | $5,825,826 | September 30, 2024 | July 31, 2029 | JOHNSON, ERIK C.B. | reporter.nih.gov |
| Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pathology: Elucidating neuroprotective effects in the racially and ethnically diverse SPRINT trial | NIH | National Institute on Aging | 2025 | $5,789,766 | September 30, 2025 | June 30, 2030 | BRESS, ADAM P | reporter.nih.gov |
| VCID and Stroke in a Bi-racial National Cohort | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $5,761,773 | September 24, 2001 | September 16, 2024 | JUDD, SUZANNE E | reporter.nih.gov |
| First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD) | NIH | National Institute on Aging | 2021 to 2023 | $5,749,685 | September 1, 2021 | August 31, 2024 | YOLES, ETI | reporter.nih.gov |
| Genetic models of sporadic Alzheimers Disease in the marmoset | NIH | National Institute on Aging | 2021 to 2024 | $5,749,378 | September 1, 2021 | June 30, 2026 | LEE, KUO-FEN | reporter.nih.gov |
| The Alzheimer Disease Sequence Analysis Collaborative | NIH | National Institute on Aging | 2021 to 2022 | $5,746,500 | September 30, 2018 | August 31, 2025 | HAINES, JONATHAN L | reporter.nih.gov |
| Discovery of Drugs that Modulate Neuroinflammation for the treatment of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $5,740,022 | June 15, 2021 | May 31, 2026 | HODGETTS, KEVIN | reporter.nih.gov |
| Cerebral tau deposition and comorbid cerebrovascular disease across the Alzheimer's disease continuum in Mexican Americans | NIH | National Institute on Aging | 2024 to 2025 | $5,730,361 | August 15, 2024 | August 31, 2029 | HABES, MOHAMAD | reporter.nih.gov |
| NPTX2: Preserving memory circuits in normative aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $5,697,103 | May 1, 2021 | April 30, 2027 | BARNES, CAROL A. | reporter.nih.gov |
| Brain pathologies, reserve and cognition in aging and dementia | NIH | National Institute on Aging | 2022 to 2025 | $5,694,414 | March 1, 2009 | March 31, 2027 | TOMASZEWSKI-FARIAS, SARAH E | reporter.nih.gov |
| A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects | NIH | National Institute on Aging | 2021 to 2022 | $5,678,762 | February 1, 2021 | May 31, 2024 | GALASKO, DOUGLAS R | reporter.nih.gov |
| NBER Center for Aging and Health Research | NIH | National Institute on Aging | 2021 to 2025 | $5,663,258 | August 1, 1997 | August 31, 2027 | CUTLER, DAVID M | reporter.nih.gov |
| Earlier-Life Predictors of Midlife Risk Factors for Dementia: A 35-Year Follow-up (Revision) | NIH | National Institute on Aging | 2023 to 2025 | $5,646,724 | March 1, 2023 | February 29, 2028 | REBOK, GEORGE W. | reporter.nih.gov |
| Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain | NIH | National Institute on Aging | 2022 to 2025 | $5,619,647 | April 1, 2022 | January 31, 2027 | BUCHMAN, ARON S | reporter.nih.gov |
| Adversity, Aging and ADRD Risk among the Global Poor: A Biosocial Lifecourse Approach | NIH | National Institute on Aging | 2023 to 2025 | $5,604,169 | May 1, 2023 | February 28, 2029 | KOHLER, HANS-PETER | reporter.nih.gov |
| Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and Symptomatology | NIH | National Institute on Aging | 2021 to 2024 | $5,592,774 | September 15, 2021 | May 31, 2026 | SHIVELY, CAROL A. | reporter.nih.gov |
| Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $5,585,106 | July 1, 2020 | June 30, 2026 | MURROUGH, JAMES WARREN | reporter.nih.gov |
| Atlas for neuronal and glial cell types selectively vulnerable to proteinopathies during progression of Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2024 | $5,580,121 | June 1, 2023 | February 28, 2029 | LEE, KUO-FEN | reporter.nih.gov |
| Early risk factors of accelerated neural aging trajectories and cognitive decline: a nonhuman primate longitudinal model | NIH | National Institute on Aging | 2021 to 2025 | $5,565,416 | August 1, 2021 | April 30, 2027 | SANCHEZ, MAR M | reporter.nih.gov |
| Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study | NIH | National Institute on Aging | 2021 to 2023 | $5,561,015 | September 15, 2019 | August 31, 2025 | LEE, JINKOOK | reporter.nih.gov |
| Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,552,808 | April 1, 2022 | March 31, 2027 | LIMA, JOAO A C | reporter.nih.gov |
| Roles of Gray Matter Brain Aging and Small Vessel Disease in AD Pathophysiology | NIH | National Institute on Aging | 2021 | $5,546,075 | March 1, 2005 | February 29, 2024 | AIZENSTEIN, HOWARD J | reporter.nih.gov |
| Alzheimer’s Disease Related Biomarkers following SARS-CoV-2 Infection | NIH | National Institute on Aging | 2022 to 2025 | $5,518,240 | June 15, 2022 | March 31, 2027 | WISNIEWSKI, THOMAS M | reporter.nih.gov |
| Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia | NIH | National Institute on Aging | 2022 to 2025 | $5,516,416 | September 30, 2022 | May 31, 2027 | HAMILTON, ROY H | reporter.nih.gov |
| Primary Care Detection of Cognitive Impairment Leveraging Health and Consumer Technologies in Underserved Communities: The MyCog Trial | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $5,515,593 | September 25, 2017 | August 31, 2027 | WOLF, MICHAEL S | reporter.nih.gov |
| Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | NIH | National Institute on Aging | 2021 to 2025 | $5,508,448 | February 1, 2021 | April 30, 2027 | ELIZAROV, ARKADIJ | reporter.nih.gov |
| Reducing Disparities in Dementia and VCID Outcomes in a Multicultural Rural Population | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,484,212 | March 6, 2020 | March 21, 2025 | GALVIN, JAMES E | reporter.nih.gov |
| Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network | NIH | National Institute on Aging | 2023 to 2025 | $5,472,632 | September 15, 2023 | May 31, 2028 | MIELKE, MICHELLE M | reporter.nih.gov |
| An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populations | NIH | National Institute on Aging | 2023 to 2025 | $5,455,529 | August 15, 2023 | June 30, 2028 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| The role of 24-hour activity cycles in preserving cognitive function and preventing Alzheimer's disease and related dementias | NIH | National Institute on Aging | 2022 | $5,450,271 | June 1, 2022 | May 31, 2025 | DIAZ, KEITH M | reporter.nih.gov |
| Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease | NIH | National Institute on Aging | 2021 to 2025 | $5,445,522 | September 30, 2021 | May 31, 2027 | KELLIS, MANOLIS | reporter.nih.gov |
| Center for Label-free Imaging and Multiscale Biophotonics (CLIMB) | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $5,439,409 | September 30, 2022 | June 20, 2027 | BOPPART, STEPHEN A | reporter.nih.gov |
| Characterizing TDP-43 related hippocampal degeneration and memory loss in aging | NIH | National Institute on Aging | 2021 to 2024 | $5,432,993 | June 1, 2020 | March 31, 2026 | SCHNEIDER, JULIE A. | reporter.nih.gov |
| THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE | NIH | National Institute of Mental Health | 2023 to 2025 | $5,429,596 | August 23, 2025 | August 22, 2026 | MOORE, DAVID J | reporter.nih.gov |
| Translational Control in Memory and Brain Disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,426,946 | May 1, 2021 | April 30, 2029 | KLANN, ERIC | reporter.nih.gov |
| Vascular-immune mechanisms of cerebral amyloid angiopathy and Alzheimer's pathology | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $5,423,836 | September 19, 2024 | August 31, 2027 | YANG, ANDREW CHRIS | reporter.nih.gov |
| Identification of cognitive decline and dementia: Prediction by everyday driving behaviors and physiological responses | NIH | National Institute on Aging | 2021 to 2024 | $5,415,921 | September 15, 2020 | May 31, 2026 | GIORDANI, BRUNO | reporter.nih.gov |
| Naturalistic driving as a functional neurobehavioral marker of preclinical and symptomatic Alzheimer disease | NIH | National Institute on Aging | 2021 to 2024 | $5,397,726 | September 15, 2020 | May 31, 2026 | BABULAL, GANESH M | reporter.nih.gov |
| Leadership in AD/ADRD Drug Discovery | NIH | National Institute on Aging | 2021 to 2025 | $5,389,748 | September 1, 2021 | August 31, 2027 | LIPTON, STUART A | reporter.nih.gov |
| Multi-morbidity 3-City Alzheimer's Disease EHR Study (M3AD Study) | NIH | National Institute on Aging | 2024 | $5,387,161 | September 17, 2024 | August 31, 2025 | DESVARIEUX, MOISE | reporter.nih.gov |
| Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study - Revision | NIH | National Institute on Aging | 2021 to 2024 | $5,354,279 | September 15, 2002 | May 31, 2025 | KAWAS, CLAUDIA H. | reporter.nih.gov |
| Investigating the Benefits of Remotely-supervised Neuromodulation in Primary Progressive Aphasia | NIH | National Institute on Aging | 2025 | $5,343,452 | September 15, 2025 | August 31, 2029 | HENRY, MAYA | reporter.nih.gov |
| FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants. | NIH | National Institute on Aging | 2025 | $5,308,961 | August 1, 2025 | July 31, 2030 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $5,303,779 | September 15, 2021 | August 31, 2023 | RASCHKE, WILLIAM C | reporter.nih.gov |
| Validation of Video Administration of a Modified UDSv3 Cognitive Battery | NIH | National Institute on Aging | 2022 to 2025 | $5,299,547 | March 1, 2022 | February 28, 2027 | SACHS, BONNIE | reporter.nih.gov |
| Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP | NIH | National Institute on Aging | 2021 to 2025 | $5,284,458 | June 1, 2019 | March 31, 2029 | NEYLAN, THOMAS C | reporter.nih.gov |
| Advancing Diagnosis of Dementia in Primary Care Practice(ADDPCP) | NIH | National Institute on Aging | 2024 to 2025 | $5,273,754 | September 1, 2024 | May 31, 2029 | ROSEN, HOWARD J | reporter.nih.gov |
| Astrocyte and neuron brain-region and compartment-specific proteome dynamics in aging and Alzheimer’s disease | NIH | National Institute on Aging | 2021 to 2025 | $5,247,255 | September 30, 2021 | July 31, 2026 | KHAKH, BALJIT | reporter.nih.gov |
| Advancing RNA Therapeutics for Huntington’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $5,226,511 | February 1, 2020 | January 31, 2026 | ARONIN, NEIL | reporter.nih.gov |
| Vervet Research Colony as a Biomedical Resource | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $5,196,934 | July 1, 2004 | March 31, 2030 | JORGENSEN, MATTHEW | reporter.nih.gov |
| Tau based Monkey model of Alzheimer's Disease; Structure and Function | NIH | National Institute on Aging | 2021 to 2024 | $5,183,524 | September 1, 2021 | May 31, 2026 | MORRISON, JOHN H | reporter.nih.gov |
| Digital Health Technologies for Monitoring Motor Function in Progressive Supranuclear Palsy and Dementia with Lewy Bodies | NIH | National Institute on Aging | 2025 | $5,174,076 | September 1, 2025 | August 31, 2029 | VAZIRI, ASHKAN | reporter.nih.gov |
| Mexican Teachers Cohort Study: Genetics and Cognitive Function | NIH | National Institute on Aging | 2024 to 2025 | $5,167,040 | September 30, 2024 | August 31, 2029 | GRODSTEIN, FRANCINE | reporter.nih.gov |
| Environmental Exposures and Brain Health | NIH | National Institute on Aging | 2025 | $5,164,012 | September 1, 2025 | August 31, 2029 | JAMES, PETER | reporter.nih.gov |
| Characterizing the AD Metabolome in Brain Tissue Samples of Individuals from Diverse Populations | NIH | National Institute on Aging | 2021 to 2022 | $5,150,658 | September 30, 2018 | August 31, 2025 | KADDURAH-DAOUK, RIMA F | reporter.nih.gov |
| Using a Health Disparity Research Framework to examine mechanisms linking Obstructive Sleep Apnea with higher Alzheimer’s disease risk in older Blacks/African-Americans | NIH | National Institute on Aging | 2023 to 2025 | $5,141,003 | June 1, 2023 | April 30, 2028 | BUBU, OMONIGHO A MICHAEL | reporter.nih.gov |
| Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD | NIH | National Institute on Aging | 2021 to 2025 | $5,121,493 | September 30, 2021 | May 31, 2027 | SPIRA, ADAM PETER | reporter.nih.gov |
| Developing the Privately Owned Companion Dog as a Model for Alzheimers Disease | NIH | National Institute on Aging | 2021 to 2024 | $5,115,565 | September 1, 2021 | May 31, 2025 | KEENE, CHRISTOPHER DIRK | reporter.nih.gov |
| The Neuropathologic Landscape of Alzheimer's Disease in Hispanic Decedents | NIH | National Institute on Aging | 2021 to 2025 | $5,113,642 | August 1, 2019 | July 31, 2029 | DUGGER, BRITTANY NICOLE | reporter.nih.gov |
| Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $5,093,143 | September 1, 2023 | August 31, 2028 | LAGIER-TOURENNE, CLOTILDE | reporter.nih.gov |
| Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial | NIH | National Institute on Aging | 2021 to 2024 | $5,087,598 | September 15, 2020 | May 31, 2025 | VERGHESE, JOE | reporter.nih.gov |
| A Precision Medicine Approach for the Study of Targetable Pathways in Vascular Dementia | NIH | National Institute on Aging | 2022 to 2025 | $5,086,657 | February 1, 2022 | November 30, 2026 | GOATE, ALISON M | reporter.nih.gov |
| ARMCADA - Advancing Reliable Measurement in Cognitive Aging and Decision-making Ability | NIH | National Institute on Aging | 2023 to 2025 | $5,076,835 | April 1, 2023 | March 31, 2028 | GERSHON, RICHARD | reporter.nih.gov |
| Enhancing Sleep Quality for Nursing Home Residents with Dementia: Pragmatic Trial | NIH | National Institute on Aging | 2023 to 2025 | $5,065,841 | September 15, 2019 | April 30, 2027 | SNOW, A LYNN | reporter.nih.gov |
| Dietary Restriction, GH/IGF-1 & Mechanisms of Cellular Protection and Regeneration | NIH | National Institute on Aging | 2021 to 2023 | $5,057,227 | February 15, 2018 | January 31, 2024 | LONGO, VALTER D. | reporter.nih.gov |
| Study of Latinos Investigation of Neurocognitive Aging 2 | NIH | National Institute on Aging | 2021 | $5,055,467 | September 1, 2015 | April 30, 2023 | GONZALEZ, HECTOR M | reporter.nih.gov |
| AI + Aging (a2) Coordinating Center for the NIA Artificial Intelligence and Technology Collaboratories for Aging Research (AITCs) | NIH | National Institute on Aging | 2021 to 2025 | $5,055,437 | September 30, 2021 | May 31, 2027 | LI, ROSE MARIA | reporter.nih.gov |
| Brain Health and Ethnic Disparities in ADRD Risk: The Case of Arab Americans | NIH | National Institute on Aging | 2021 to 2025 | $5,040,162 | April 1, 2021 | March 31, 2027 | ANTONUCCI, TONI CLAUDETTE | reporter.nih.gov |
| Cardiorenal and Metabolic Diseases Research Center | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $5,037,364 | September 5, 2013 | April 30, 2023 | HALL, JOHN E | reporter.nih.gov |
| ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings | NIH | National Institute on Aging | 2021 to 2025 | $5,006,816 | September 30, 2020 | May 31, 2026 | NOWINSKI, CINDY J. | reporter.nih.gov |
| Clinical & biological signatures of post-traumatic neurodegeneration: Leveraging the TBI Model Systems of Care to accelerate in vivo diagnosis of the late effects of TBI (LETBI) | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $5,005,696 | September 1, 2022 | August 31, 2025 | DAMS-O'CONNOR, KRISTEN | reporter.nih.gov |
| Pragmatic Trial of the Effectiveness and Cost-Effectiveness of Dementia Care | NIH | National Institute on Aging | 2021 to 2023 | $4,994,799 | September 30, 2018 | May 31, 2025 | REUBEN, DAVID B. | reporter.nih.gov |
| USC-Yale Roybal Center for Behavioral Interventions in Aging | NIH | National Institute on Aging | 2021 to 2025 | $4,993,847 | September 30, 2004 | May 31, 2029 | DOCTOR, JASON N. | reporter.nih.gov |
| Multi-scale and multi-modality imaging of neuropathology in VCID | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $4,964,481 | September 22, 2023 | August 31, 2028 | GE, YULIN | reporter.nih.gov |
| IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease. | NIH | National Institute on Aging | 2021 to 2023 | $4,958,940 | May 1, 2020 | April 30, 2026 | RODGERS, KATHLEEN E. | reporter.nih.gov |
| Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) | NIH | National Institute on Aging | 2021 to 2024 | $4,956,317 | September 1, 2020 | August 31, 2025 | VAZQUEZ, MIGUEL A | reporter.nih.gov |
| Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $4,943,234 | September 15, 2022 | June 30, 2027 | SEYFRIED, NICHOLAS THOMAS | reporter.nih.gov |
| Botanicals enhancing neurological and functional resilience in aging (BENFRA) | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $4,931,479 | July 1, 2020 | June 30, 2026 | SOUMYANATH, AMALA | reporter.nih.gov |
| Contribution of Longitudinal Neighborhood Determinants to Cognitive Health and Dementia Disparities within a Multi-Ethnic Cohort | NIH | National Institute on Aging | 2021 to 2025 | $4,930,675 | May 15, 2021 | February 28, 2027 | HIRSCH, JANA ARIEL | reporter.nih.gov |
| Assessing Novel Biomarkers for Cognitive Fluctuations in DLB | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $4,924,374 | September 1, 2025 | July 31, 2029 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| Preclinical and early clinical development of a GABA-A a5 PAM | NIH | National Institute on Aging | 2022 to 2025 | $4,921,400 | September 1, 2022 | August 31, 2026 | PAYIE, KENNETH G | reporter.nih.gov |
| Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults | NIH | National Institute on Aging | 2021 to 2025 | $4,900,406 | April 1, 2021 | March 31, 2027 | VANDERHORST, VERONIQUE | reporter.nih.gov |
| Molecular Diversity Among Hippocampal and Entorhinal Cells in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $4,896,138 | September 30, 2021 | August 31, 2024 | SESTAN, NENAD | reporter.nih.gov |
| Health of the Cholinergic System and Risk for Alzheimer's Disease in Postmenopausal Women | NIH | National Institute on Aging | 2021 to 2023 | $4,889,665 | September 15, 2019 | May 31, 2026 | DUMAS, JULIE A | reporter.nih.gov |
| Federated digital pathology platform for AD/ADRD research and diagnostics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $4,861,895 | September 20, 2023 | August 31, 2028 | NELSON, PETER T. | reporter.nih.gov |
| Investigations of the protein aggregation inhibitor NU-9 and its derivatives: mode of action and impact on Alzheimer’s disease and related dementias | NIH | National Institute on Aging | 2021 to 2025 | $4,851,218 | August 1, 2019 | July 31, 2029 | OZDINLER, PEMBE HANDE | reporter.nih.gov |
| CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SYSTEM (CROMS) 2.0 | NIH | National Institute on Drug Abuse | 2025 | $4,851,124 | July 1, 2025 | June 30, 2026 | reporter.nih.gov | |
| Upregulated Norepinephrine Synthesis Capacity in Aging | NIH | National Institute on Aging | 2022 to 2025 | $4,846,427 | June 1, 2022 | March 31, 2027 | BERRY, ANNE SHIVELY | reporter.nih.gov |
| China Health and Retirement Longitudinal study | NIH | National Institute on Aging | 2021 to 2024 | $4,842,807 | June 15, 2020 | February 28, 2025 | WANG, YAFENG | reporter.nih.gov |
| Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project | NIH | National Institute of Mental Health | 2022 to 2025 | $4,842,533 | August 1, 2013 | May 31, 2027 | MACKIN, ROBERT SCOTT | reporter.nih.gov |
| Web-based Automated Imaging Differentiation of Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,837,150 | April 1, 2021 | March 31, 2027 | VAILLANCOURT, DAVID E | reporter.nih.gov |
| Reimagining Precision Medicine Approaches to AD Diagnosis | NIH | National Institute on Aging | 2021 to 2025 | $4,816,964 | April 15, 2021 | March 31, 2027 | RABINOVICI, GIL DAN | reporter.nih.gov |
| [18F]-PU-AD epichaperome PET imaging probe | NIH | National Institute on Aging | 2022 to 2025 | $4,816,476 | June 15, 2022 | May 31, 2027 | CHIOSIS, GABRIELA | reporter.nih.gov |
| Vasculo-neuronal pathophysiological interface in Alzheimer’s and Atherosclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $4,815,513 | September 18, 2024 | August 31, 2027 | IRUELA-ARISPE, M. LUISA | reporter.nih.gov |
| Hippocampal-dependent memory decline in aging and early Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $4,814,781 | February 1, 2022 | January 31, 2027 | MORMINO, ELIZABETH | reporter.nih.gov |
| Achieving specificity in imaging neurodegeneration with visible light Optical Coherence Tomography | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,798,178 | September 15, 2024 | September 14, 2027 | SRINIVASAN, VIVEK JAY | reporter.nih.gov |
| Cognitive Resilience among Older Samoans | NIH | National Institute on Aging | 2021 to 2025 | $4,777,899 | March 1, 2021 | February 28, 2027 | LEVY, BECCA R | reporter.nih.gov |
| Comparative Single-Cell Epigenomic Analysis of AD-like Pathogenesis in Unconventional Animal Models | NIH | National Institute on Aging | 2021 to 2024 | $4,771,429 | September 1, 2021 | May 31, 2025 | XU, XIANGMIN | reporter.nih.gov |
| The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory | NIH | National Institute on Aging | 2024 to 2025 | $4,768,289 | August 15, 2024 | July 31, 2029 | KADDURAH-DAOUK, RIMA F | reporter.nih.gov |
| Spatial navigation, sex hormones, and the aging brain | NIH | National Institute on Aging | 2025 | $4,765,698 | August 5, 2025 | July 31, 2029 | JACOBS, EMILY G | reporter.nih.gov |
| Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment | NIH | National Institute on Aging | 2021 to 2023 | $4,763,535 | May 15, 2020 | April 30, 2025 | WATTERSON, DANIEL MARTIN | reporter.nih.gov |
| Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $4,742,300 | September 30, 1992 | August 31, 2027 | YANKNER, BRUCE A | reporter.nih.gov |
| Novel retinal higher-order capillary hemodynamics imaging for detecting cerebral small vessel disease | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,719,171 | September 15, 2024 | September 14, 2027 | WANG, JIANHUA | reporter.nih.gov |
| Center for Molecular Imaging Technology & Translation (CMITT) | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $4,717,243 | September 30, 2017 | April 30, 2027 | EL FAKHRI, GEORGES | reporter.nih.gov |
| Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $4,709,163 | May 15, 2014 | August 31, 2023 | ZHANG, BIN | reporter.nih.gov |
| Primary Progressive Aphasia: Cognition, Anatomy and Progression | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $4,705,247 | July 15, 2004 | August 31, 2025 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level | NIH | National Institute on Aging | 2024 to 2025 | $4,701,117 | April 15, 2024 | March 31, 2029 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Center to Accelerate Population Research in Alzheimer's (CAPRA) | NIH | National Institute on Aging | 2021 to 2025 | $4,693,477 | August 1, 2020 | August 31, 2027 | BYNUM, JULIE PW | reporter.nih.gov |
| Defining the molecular spectrum of white matter vascular lesions | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $4,693,249 | September 17, 2024 | August 31, 2027 | HINMAN, JASON D | reporter.nih.gov |
| Brain mitochondrial PET imaging and 31P-MR spectroscopy to dissect the role of mitochondrial dysfunction in bioenergetic dysregulation in Dementia with Lewy Bodies pathogenesis | NIH | National Institute on Aging | 2023 to 2025 | $4,683,243 | September 15, 2023 | May 31, 2029 | BERMAN, SARAH B | reporter.nih.gov |
| Learning the Regulatory Code of Alzheimer's Disease Genomes | NIH | National Institute on Aging | 2021 to 2024 | $4,650,607 | September 1, 2020 | August 31, 2025 | RAJ, TOWFIQUE | reporter.nih.gov |
| Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS) | NIH | National Institute on Aging | 2021 | $4,626,374 | September 30, 2017 | August 31, 2024 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures | NIH | National Institute on Aging | 2022 to 2025 | $4,622,158 | February 1, 2022 | January 31, 2027 | EISENBERG, DAVID | reporter.nih.gov |
| Sexual dimorphic cell type and connectivity atlases of the aging and AD mouse brains | NIH | National Institute on Aging | 2023 to 2025 | $4,621,936 | September 1, 2023 | May 31, 2028 | DONG, HONG-WEI | reporter.nih.gov |
| Brain fluid clearance and misfolded protein dynamics following traumatic brain injury | NIH | National Institute on Aging | 2023 to 2025 | $4,618,282 | September 30, 2023 | June 30, 2029 | BUTLER, TRACY A. | reporter.nih.gov |
| Aging of Emotion Circuitry and Risk for Alzheimer's disease: Impact of Sex, Immunity, and Fetal Origins | NIH | National Institute on Aging | 2021 to 2025 | $4,614,422 | June 15, 2018 | February 28, 2029 | GOLDSTEIN, JILL M | reporter.nih.gov |
| Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $4,613,790 | December 15, 2015 | November 30, 2023 | STERN, ROBERT A | reporter.nih.gov |
| Early Age-Related Hearing Loss Investigation (EARHLI): A Randomized Controlled Trial to Assess Mechanisms Linking Early Age-Related Hearing Loss and Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 to 2025 | $4,610,876 | September 15, 2022 | August 31, 2027 | GOLUB, JUSTIN SCOTT | reporter.nih.gov |
| Colorado Adoption/Twin Study of Lifespan behavioral development & cognitive aging (CATSLife2) | NIH | National Institute on Aging | 2021 to 2022 | $4,599,025 | June 1, 2015 | May 31, 2023 | REYNOLDS, CHANDRA A | reporter.nih.gov |
| Model-based cerebrovascular markers extracted from hemodynamic data for diagnosing MCI or AD and predicting disease progression. | NIH | National Institute on Aging | 2021 to 2022 | $4,594,525 | September 1, 2018 | May 31, 2025 | MARMARELIS, VASILIS Z | reporter.nih.gov |
| Digital speech markers for early detection of Alzheimer’s disease in a longitudinal racially and ethnically diverse cohort | NIH | National Institute on Aging | 2025 | $4,591,694 | September 5, 2025 | August 31, 2029 | VONK, JET M.J. | reporter.nih.gov |
| Illuminating the APOE Locus with Long-Read Sequencing and Targeted Genomics | NIH | National Institute on Aging | 2021 to 2025 | $4,590,209 | September 1, 2021 | May 31, 2026 | GREICIUS, MICHAEL D | reporter.nih.gov |
| Cell Type-Specific Proteins that Promote Resilience to Cognitive Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2025 | $4,581,949 | September 30, 2021 | May 31, 2027 | KACZOROWSKI, CATHERINE COOK | reporter.nih.gov |
| Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches | NIH | National Institute on Aging | 2021 to 2022 | $4,574,416 | September 30, 2018 | August 31, 2025 | DESTEFANO, ANITA L | reporter.nih.gov |
| First in Human Study of a Tau Self-Association Small Molecule Inhibitor in Healthy Volunteers | NIH | National Institute on Aging | 2022 to 2024 | $4,567,070 | August 1, 2022 | July 31, 2025 | ERHARDT, WILLIAM A. | reporter.nih.gov |
| Development of a MT-stabilizing agent for the treatment of tauopathies | NIH | National Institute on Aging | 2024 to 2025 | $4,559,463 | September 1, 2024 | August 31, 2027 | CAFFREY, CONOR | reporter.nih.gov |
| USC/UCLA Center on Biodemography and Population Health | NIH | National Institute on Aging | 2021 to 2025 | $4,559,155 | August 15, 1999 | August 31, 2027 | CRIMMINS, EILEEN M | reporter.nih.gov |
| The wandering nerve: gateway to boost Alzheimer's disease related cognitive performance | NIH | National Institute on Aging | 2021 to 2025 | $4,558,716 | May 1, 2021 | April 30, 2027 | JACOBS, HEIDI IRMA | reporter.nih.gov |
| The CHARMED model: a multimorbidity simulation model for people aging with HIV | NIH | National Institute on Aging | 2021 to 2025 | $4,557,763 | April 1, 2021 | March 31, 2027 | HYLE, EMILY PARKER | reporter.nih.gov |
| ACTIVE MIND: An adaptive clinical trial of cognitive training to improve function and delay dementia | NIH | National Institute on Aging | 2024 | $4,555,241 | September 1, 2024 | August 31, 2027 | EDWARDS, JERRI | reporter.nih.gov |
| Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias | NIH | National Institute on Aging | 2022 to 2024 | $4,547,001 | September 15, 2022 | August 31, 2025 | MURRAY, ANNE M | reporter.nih.gov |
| Completion of Non-clinical long-term GLP safety and GMP manufacture for first-in-class neuron regenerative therapy, NNI-362 Phase 2 POC AD trial | NIH | National Institute on Aging | 2023 to 2024 | $4,543,556 | September 1, 2023 | August 31, 2025 | KELLEHER-ANDERSSON, JUDITH A | reporter.nih.gov |
| An Acquisition and Analysis Pipeline for Integrating MRI and Neuropathology in TBI-related Dementia and VCID | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $4,539,313 | September 22, 2023 | August 31, 2028 | VAN DER KOUWE, ANDRE JAN WILLEM | reporter.nih.gov |
| Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2025 | $4,533,578 | June 1, 2023 | February 29, 2028 | FRANK, LAWRENCE R | reporter.nih.gov |
| Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD | NIH | National Institute on Aging | 2022 to 2025 | $4,533,350 | September 30, 2022 | May 31, 2027 | GLABE, CHARLES G. | reporter.nih.gov |
| Center on the Economics and Demography of Aging | NIH | National Institute on Aging | 2021 to 2025 | $4,524,890 | July 1, 1997 | August 31, 2027 | DOW, WILLIAM H | reporter.nih.gov |
| Supplemental Request: Therapeutic APOE2 overexpression for early Alzheimer's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $4,517,405 | May 1, 2019 | April 30, 2023 | DAVIDSON, BEVERLY L. | reporter.nih.gov |
| IMPACT-ADRD: Investigating the Multi-omics Perturbations Associated with Complex Environmental Toxicants and their Contribution to Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2024 to 2025 | $4,511,944 | August 15, 2024 | July 31, 2029 | HUELS, ANKE | reporter.nih.gov |
| Capillaries as a Sensory Web that Controls Cerebral Blood Flow in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,511,697 | January 1, 2019 | December 31, 2026 | NELSON, MARK T | reporter.nih.gov |
| Targeting REST in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $4,505,937 | May 1, 2021 | April 30, 2027 | YANKNER, BRUCE A | reporter.nih.gov |
| African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies | NIH | National Institute on Aging | 2021 to 2023 | $4,504,699 | September 15, 2016 | May 31, 2024 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Spousal dementia caregivers: Risk for accelerated aging | NIH | National Institute on Aging | 2021 to 2024 | $4,503,425 | September 15, 2020 | May 31, 2026 | CHRISTIAN, LISA MICHELLE | reporter.nih.gov |
| A Phase 1b Multiple Ascending Dose Study of the Safety and Tolerability of BMS-984923 in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $4,500,015 | September 30, 2021 | August 31, 2025 | MECCA, ADAM PETER | reporter.nih.gov |
| A Pragmatic Crossover Trial to Test the Effectiveness of a Novel Lighting System to Reduce Nighttime Falls in Persons with Alzheimer’s Disease and Related Dementias | NIH | National Institute on Aging | 2022 to 2025 | $4,499,469 | July 1, 2022 | June 30, 2028 | ZIMMERMAN, SHERYL | reporter.nih.gov |
| Ambulatory Methods for Measuring Cognitive Change | NIH | National Institute on Aging | 2021 to 2022 | $4,488,274 | September 15, 2018 | May 31, 2025 | SLIWINSKI, MARTIN J | reporter.nih.gov |
| Development and Validation of a Marmoset Model of Late-Onset Alzheimer Disease Based on Tau Seeding | NIH | National Institute on Aging | 2021 to 2024 | $4,484,803 | August 15, 2021 | May 31, 2025 | SILVA, AFONSO C | reporter.nih.gov |
| Prognostic Implications of Home-Based Blood Pressure Monitoring in Older Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,461,092 | July 20, 2021 | May 31, 2027 | JURASCHEK, STEPHEN P | reporter.nih.gov |
| Innovative Deep Phenotyping of African Americans at Risk for Alzheimers disease | NIH | National Institute on Aging | 2023 to 2025 | $4,456,098 | June 1, 2023 | February 29, 2028 | LOEWENSTEIN, DAVID | reporter.nih.gov |
| Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $4,452,998 | September 30, 2018 | May 31, 2028 | ALBERS, MARK W | reporter.nih.gov |
| A global epidemiology of cognitive impairment and dementia due to Alzheimer's disease and related disorders: the COSMIC Collaboration | NIH | National Institute on Aging | 2023 to 2025 | $4,445,528 | September 15, 2017 | June 30, 2028 | SACHDEV, PERMINDER S | reporter.nih.gov |
| A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $4,440,050 | September 30, 2018 | May 31, 2025 | MOHS, RICHARD CHARLES | reporter.nih.gov |
| Cognitive Computing of Alzheimer's Disease Genes and Risk | NIH | National Institute on Aging | 2021 to 2025 | $4,431,314 | July 1, 2021 | June 30, 2027 | LICHTARGE, OLIVIER | reporter.nih.gov |
| Combining Computational Methods, RDoC, and Big Neuroimaging Data to Understand Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $4,421,675 | September 30, 2022 | August 31, 2027 | NICKERSON, LISA D | reporter.nih.gov |
| Measurement and Analysis of Aging, Cognition and Alzheimer's Disease and Related Dementia (ADRD) Risk Factors at Midlife in the Kenya Life Panel Survey (KLPS) | NIH | National Institute on Aging | 2022 to 2025 | $4,411,923 | May 15, 2022 | April 30, 2027 | MIGUEL, EDWARD ANDREW | reporter.nih.gov |
| Project HoPe: Achieving Home Discharge for institutionally-bound Patients with PROMs, AI, and the EHR | NIH | National Institute on Aging | 2022 to 2025 | $4,403,711 | August 3, 2022 | April 30, 2028 | CHEVILLE, ANDREA LYNNE | reporter.nih.gov |
| Alzheimer's dementia onset and progression in international cohorts (Amended) | NIH | National Institute on Aging | 2021 to 2022 | $4,403,042 | September 30, 2018 | May 31, 2025 | MASTERS, COLIN | reporter.nih.gov |
| Cognitive Impairment and Dementia, Vascular Brain Injury, and Atrial Myopathy: Implications for Prevention of Alzheimer's Disease-Related Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $4,390,219 | September 20, 2023 | August 31, 2026 | CHEN, LIN YEE | reporter.nih.gov |
| Precursors of Stroke Incidence and Prognosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $4,368,194 | December 1, 1981 | August 31, 2028 | ROMERO, JOSE RAFAEL | reporter.nih.gov |
| 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical Trial | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $4,365,934 | September 15, 2017 | October 31, 2024 | VERGHESE, JOE | reporter.nih.gov |
| Optimizing a closed-loop digital meditation intervention for remediating cognitive decline and reducing stress in older adults | NIH | National Institute on Aging | 2022 to 2024 | $4,364,410 | June 1, 2022 | May 31, 2027 | ZIEGLER, DAVID A | reporter.nih.gov |
| COGNITIVE TRAINING AND NEUROPLASTICITY IN MILD COGNITIVE IMPAIRMENT | NIH | National Institute on Aging | 2021 to 2025 | $4,364,339 | July 15, 2017 | February 28, 2029 | DEVANAND, DAVANGERE P | reporter.nih.gov |
| VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $4,361,625 | September 24, 2024 | August 31, 2027 | LEE, JIN-MOO | reporter.nih.gov |
| Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,359,590 | December 1, 2016 | November 30, 2024 | GITLER, AARON D. | reporter.nih.gov |
| Vanderbilt Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2023 | $4,356,837 | August 15, 2020 | July 31, 2025 | JEFFERSON, ANGELA L. | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Southern California | Los Angeles, CA | 158 | $538.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 216 | $534.2 million | 0 | $0 |
| Washington University | Saint Louis, MO | 193 | $509.8 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 267 | $487.5 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 235 | $474.5 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 129 | $391.2 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 254 | $388.5 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 173 | $353.7 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 148 | $349.3 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 112 | $339 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 161 | $313.9 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 102 | $304.5 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 148 | $297.1 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 62 | $254.2 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 111 | $236.4 million | 0 | $0 |
| Emory University | Atlanta, GA | 130 | $227 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 111 | $223.1 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 95 | $215.5 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 112 | $215.4 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 71 | $205.5 million | 0 | $0 |
| Stanford University | Stanford, CA | 137 | $184.7 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 94 | $170.6 million | 0 | $0 |
| University of Washington | Seattle, WA | 88 | $168.5 million | 0 | $0 |
| Brown University | Providence, RI | 71 | $165.3 million | 0 | $0 |
| Yale University | New Haven, CT | 111 | $160.9 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 52 | $158.4 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 75 | $151.6 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 58 | $150 million | 0 | $0 |
| Duke University | Durham, NC | 79 | $149 million | 0 | $0 |
| University of California at Davis | Davis, CA | 68 | $148 million | 0 | $0 |
| University of Florida | Gainesville, FL | 123 | $145.4 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 96 | $139.7 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 91 | $134.9 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 88 | $132.9 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 15 | $120.8 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 58 | $120.7 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 47 | $112.6 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 82 | $112.4 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 92 | $112.4 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 71 | $111.6 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 67 | $105.2 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 77 | $99 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 49 | $97.3 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 46 | $95.5 million | 0 | $0 |
| Banner Health | Phoenix, AZ | 10 | $91.7 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 47 | $89.8 million | 0 | $0 |
| Cognition Therapeutics, Inc. | Pittsburgh, PA | 5 | $86.6 million | 0 | $0 |
| University of South Florida | Tampa, FL | 47 | $86.1 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 50 | $84.9 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 56 | $81.8 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 37 | $79 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 32 | $75.5 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 30 | $74 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 60 | $73.2 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 33 | $72.6 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 53 | $71.8 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 36 | $71.2 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 37 | $66.5 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 40 | $66.3 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 20 | $60.4 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 51 | $58.1 million | 0 | $0 |
| California Pacific Med CTR Res Institute | San Francisco, CA | 5 | $58.1 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 29 | $54.4 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 51 | $54 million | 0 | $0 |
| Allen Institute | Seattle, WA | 2 | $51.3 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 35 | $50.1 million | 0 | $0 |
| University of North Texas HLTH Sci CTR | Fort Worth, TX | 10 | $49.2 million | 0 | $0 |
| Ohio State University | Columbus, OH | 46 | $49.1 million | 0 | $0 |
| University of Rochester | Rochester, NY | 49 | $48.8 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 46 | $48.6 million | 0 | $0 |
| Augusta University | Augusta, GA | 29 | $47 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 45 | $47 million | 0 | $0 |
| Buck Institute for Research on Aging | Novato, CA | 21 | $46.5 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 32 | $45.9 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 23 | $44.7 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 31 | $44.4 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 46 | $44.3 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 22 | $43.7 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 32 | $42.4 million | 0 | $0 |
| Salk Institute for Biological Studies | La Jolla, CA | 15 | $40.2 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 9 | $39.1 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 33 | $38.8 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 29 | $38.7 million | 0 | $0 |
| Alzheon, Inc. | Framingham, MA | 1 | $36.2 million | 0 | $0 |
| National Opinion Research Center | Chicago, IL | 5 | $34.7 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 16 | $33.8 million | 0 | $0 |
| University of Chicago | Chicago, IL | 19 | $33.6 million | 0 | $0 |
| Georgetown University | Washington, DC | 29 | $32.8 million | 0 | $0 |
| Winifred Masterson Burke Med Res Inst | White Plains, NY | 2 | $32.5 million | 0 | $0 |
| Harvard University | Cambridge, MA | 9 | $32 million | 0 | $0 |
| University of Delaware | Newark, DE | 12 | $31.8 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 32 | $30.6 million | 0 | $0 |
| Hennepin Healthcare Research Institute | Minneapolis, MN | 4 | $30.3 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 8 | $29.8 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 18 | $29.5 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 23 | $29.4 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 11 | $29.3 million | 0 | $0 |
| University of Vermont & ST Agric College | Burlington, VT | 14 | $29.1 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 20 | $28.9 million | 0 | $0 |
| Seattle Inst for Biomedical/clinical Res | Seattle, WA | 16 | $28.1 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 3,603 | $3,244,517,494 | 0 | $0 |
| 2024 | 3,981 | $3,194,491,328 | 0 | $0 |
| 2023 | 3,744 | $3,216,253,160 | 0 | $0 |
| 2022 | 3,678 | $3,067,453,565 | 0 | $0 |
| 2021 | 3,442 | $2,817,748,267 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.